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Executive Summary 
 
Resolves 2005, Chapter 117 established the Blue Ribbon Commission on the Future of 
MaineCare.  The Commission was directed to submit a report with findings and 
recommendations to the Joint Standing Committee on Health and Human Services and the 
Joint Standing Committee on Appropriations and Financial Affairs by December 7, 2005. A 
copy of the resolve is included as Appendix A. The charge to the Commission includes: 
 
1. Make recommendations on how to improve the quality, adequacy, effectiveness and 
delivery of services under the program in the most cost-effective manner possible in an 
effort to ensure the sustainability of the program over time, including various options for 
providing coverage for persons in need of health care services.  
 
2. Review and make recommendations about the extent to which MaineCare is 
meeting its current and future responsibilities and include a review of the effectiveness 
of various models in financing and providing health care coverage to low-income and 
vulnerable populations, including, but not limited to, low-income families and children, 
the physically disabled, the elderly, the chronically ill and the uninsured; 
 
3. Study and report eligibility levels, service benefits, expenditures and other factors 
affecting future costs under the MaineCare program;   
 
4. Estimate future program costs, taking into account relevant factors, including, but 
not limited to, demographics; health care cost drivers; cost-savings and cost-control 
initiatives in place at the time of the study; other economic variables, including changes 
in individual and family income rates, changes in uninsured rates and changes in 
employer-based coverage rates; cost drivers and cost shifting related to coverage 
provided under the program; and other related economic factors; 
 
5. Review and summarize the economic effect of MaineCare and its role in 
maintaining Maine's health care provider network, including primary, specialty and 
acute care;    
 
6.  Provide an analysis of changes in federal funding and health care policy, 
including changes in the federal match rate formula, and how such changes will 
affect MaineCare; and 
 
7.  Review and make recommendations related to actions taken by the federal 
Medicaid Commission.   
 
The MaineCare Commission was formed during the fall of 2005, with the appointment of all 
10 members.  A copy of the membership of the MaineCare Commission is included as 
Appendix B.  The MaineCare Commission held 4 public meetings in Augusta on October 11, 
November 1, November 15 and December 6, 2005 and a final public meeting on December 
14, 2005.  
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The MaineCare Commission makes the following findings and recommendations and 
notes ongoing issues confronting the MaineCare program for future consideration.  In addition 
the MaineCare Commission voted to request legislative approval for reauthorization of the 
MaineCare Commission to work after the 2006 legislative session.  MaineCare Commission 
members are interested in working together to review Medicaid developments on the federal 
level and their implications for Maine and to discuss implementation of the MaineCare portions 
of the supplemental budget and the list of policy issues for further consideration regarding the 
MaineCare program.   
 
Findings 
 
1. MaineCare plays a critical role in the overall health care delivery system in Maine by 
providing coverage to many persons with disabilities or other serious health conditions, 
the majority of long-term care services, and other medically necessary services to low-
income families and individuals who would otherwise be uninsured.  Any program 
changes must be made carefully with consideration of the impact that those changes 
would have on the overall health care system.   
 
2. The Commission finds that state and federal law provide only limited policy direction for 
the Medicaid program.  Further, the Commission finds that due to the lack of policy 
direction and in the absence of program goals and management focused on those goals, 
MaineCare has fallen into a pattern of policy-making that is driven by fluctuations in the 
state budget. 
 
3. The Commission finds that MaineCare health care spending, like all health care 
spending, has been increasing faster than inflation, that it comprises 20% of the state 
budget, and that the State needs to better manage MaineCare in order to contain costs and 
produce accountability and predictability and to ensure the sustainability of the program.   
 
4. The Commission recognizes and commends the Department of Health and Human 
Services for designing and implementing new initiatives that will provide better services 
to MaineCare members and slow the rate of growth of expenditures and for beginning the 
planning for other initiatives, such as managed behavioral health care.  The Commission 
notes the challenges that change brings to such a large program that serves a critical role 
in Maine’s health care system.  The Commission finds that attention to Medicaid issues is 
needed on state and national levels.  In particular, the Commission notes that federal 
Medicaid program changes are under consideration as this report is being prepared and 
that the second phase recommendations of the federal Medicaid Commission are 
expected late in 2006.   
 
 
 
Recommendations 
 
    iii
1. The Commission recommends that the federal Medicaid Commission review and 
make recommendations to alter the methodology for calculating the federal medical 
assistance percentages (FMAP) so that the methodology does not contain a time lag, 
represents a better measure of state fiscal capacity and captures each state’s 
demographic structure. 
 
2. In the further implementation of managed care in MaineCare the Commission 
recommends that the Department of Health and Human Services apply primary care 
case management to a broader population, particularly to the elderly and persons with 
chronic conditions and disabilities as well as focusing on individuals with high cost 
care.  The Commission recommends that the initiative be anchored in a commitment 
to high quality services to members, substituting lower cost community-based care 
for higher cost institutional based care. 
 
3. In planning and implementing managed behavioral health care benefits as authorized 
by Public Law 2005, Chapter 457, the Commission recognizes that the initiative will 
capitate behavioral health financing only and urges the department to adopt best 
practice for integrating capitated behavioral health services with physical health 
services on an integrated basis and that it apply to adults and children. 
 
4. The Commission recommends utilizing the Maine Health Data Organization all 
claims database in the management of the MaineCare program, including use for 
managed care, quality assurance and administrative purposes. 
 
5. With regard to all MaineCare initiatives and waivers, the Commission recommends 
that the program be guided by clear policy, that goals be established to achieve that 
policy, that realistic budgets be developed to meet those goals, and that fiscal 
management be applied so that the program delivers high quality services in 
partnership with service providers and remains within budget.  In managed care 
initiatives, the Commission recommends that the goals be integration of health care 
and management of the funding of those services. This recommendation requires the 
allocation of personnel and resources to ensure adequate administrative capacity and 
success.  In addition, it envisions a new level of accountability within the program.   
 
6. The Commission endorses the current private health insurance premium program and 
believes that increased enrollment may be possible, bringing increased partnership 
with private health coverage and savings for the MaineCare program.   
 
7. The Commission recommends that the Legislature review incentives for the purchase 
of long-term care insurance, which must be viewed within the context of any federal 
restrictions and requirements.    
 
 
8. The Commission supports the incorporation of new technologies that create 
efficiencies or decrease costs, particularly electronic medical records.   
 
iv 
9. The Commission recommends that action be taken to provide immediate professional 
leadership for the Department of Health and Human Services and major offices 
within the department.  The new leaders must have vision, skills and experience to 
provide the MaineCare program with staffing, an internal evaluation component and 
long-term planning so that stability, predictability and accountability may be 
achieved.   
 
Policy issues for further consideration regarding the MaineCare program 
 
1. Simplification of federal program eligibility rules, focusing on income level and 
replacing the categories of eligibility now used. 
 
2. Consideration of the role of private market forces, including private health insurance 
and health savings accounts. 
 
3. Review of options for financing long-term care, including incentives for the purchase 
of long-term care insurance. 
 
4. Resolution of the implementation problems with the MECMS provider payment 
system. 
 
5. Resolution of the issue of timely payments to hospitals for MaineCare services.   
 
6. Consideration of the role of member co-payments, including the effect of mandatory 
and voluntary co-payments on the member, the provider and the program. 
 
7. Management of the noncategorical adult waiver to ensure access to and maximization 
of coverage.   
 
8. Consideration of the Medicare Part D drug program and its impact on MaineCare and 
related recipients, and the state budget. 
 
9. Review of the results of implementation of the State Health Plan. 
 
10. Review of federal application of prescription drug pricing based on Average 
Manufacturer Price, with state flexibility on dispensing fees, and the effect on access 
to prescription drugs. 
 
11. Review implementation of the development by the Department of Health and Human 
Services of models to better analyze and forecast program trends and growth rates. 
 
12. Clarification of the roles of the Department of Health and Human Services, Office of 
MaineCare Services and the Governor’s Office of Health Policy and Finance in the 
development and implementation of MaineCare policy. 
 
    v
13. Monitoring of the number of uninsured persons in the State, considering the costs of 
health care and health insurance and the role of MaineCare.  
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I. INTRODUCTION 
 
Resolves 2005, Chapter 117 established the Blue Ribbon Commission on the Future of 
MaineCare.  The Commission was directed to submit a report with findings and 
recommendations to the Joint Standing Committee on Health and Human Services and the Joint 
Standing Committee on Appropriations and Financial Affairs by December 7, 2005. A copy of 
the resolve is included as Appendix A. The charge to the Commission includes: 
  
 1. Make recommendations on how to improve the quality, adequacy, effectiveness and 
delivery of services under the program in the most cost-effective manner possible in 
an effort to ensure the sustainability of the program over time, including various 
options for providing coverage for persons in need of health care services.  
 
 2. Review and make recommendations about the extent to which MaineCare is meeting 
its current and future responsibilities and include a review of the effectiveness of 
various models in financing and providing health care coverage to low-income and 
vulnerable populations, including, but not limited to, low-income families and 
children, the physically disabled, the elderly, the chronically ill and the uninsured; 
 
 3. Study and report eligibility levels, service benefits, expenditures and other factors 
affecting future costs under the MaineCare program;   
 
 4. Estimate future program costs, taking into account relevant factors, including, but not 
limited to, demographics; health care cost drivers; cost-savings and cost-control 
initiatives in place at the time of the study; other economic variables, including 
changes in individual and family income rates, changes in uninsured rates and changes 
in employer-based coverage rates; cost drivers and cost shifting related to coverage 
provided under the program; and other related economic factors; 
 
 5. Review and summarize the economic effect of MaineCare and its role in maintaining 
Maine's health care provider network, including primary, specialty and acute care;   
 
 6. Provide an analysis of changes in federal funding and health care policy, including 
changes in the federal match rate formula, and how such changes will affect 
MaineCare; and 
 
 7. Review and make recommendations related to actions taken by the federal Medicaid 
Commission.   
 
The MaineCare Commission was formed during the fall of 2005, with the appointment of all 10 
members.  A copy of the membership of the MaineCare Commission is included as Appendix B.  
The MaineCare Commission held 4 public meetings in Augusta on October 11, November 1, 
November 15 and December 6, 2005 and a final public meeting on December 14, 2005.  
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Presentations were made to the MaineCare Commission by the following persons: 
 
♦ Trish Riley, Director, Governor’s Office of Health Policy and Finance 
 
♦ Jack R. Nicholas, Commissioner, Department of Health and Human Services  
 
♦ J. Michael Hall, Deputy Commissioner, Department of Health and Human Services 
 
♦ Brenda Harvey, Deputy Commissioner, Department of Health and Human Services 
 
♦ Neva Kaye, National Academy for State Health Policy 
 
♦ Bill Gardner, Financial Forecast Manager, Department of Health and Human Services 
 
♦ Maura Howard, Office of MaineCare Services, Department of Health and Human 
Services 
 
♦ Brenda McCormick, Office of MaineCare Services, Department of Health and 
Human Services 
 
♦ The Honorable Angus S. King, Jr., Former Governor of the State of Maine and Vice-
Chair of the federal Medicaid Commission 
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II. BACKGROUND INFORMATION 
 
A. FEDERAL MEDICAID LAW AND POLICY 
 
1. Federal Medicaid law  
 
 Congress enacted Title XIX of the Social Security Act in 1965, establishing a 
voluntary state-federal health care program known as Medicaid.  The program provides 
medically necessary health care to certain low-income persons, the elderly and persons 
with disabilities.  Under the Medicaid program, federal funding is available to states on a 
matching basis to assist in covering the costs of health care services provided to 
recipients and the states’ administrative costs.   
 
 As a condition of participation in the Medicaid program states must administer their 
programs in accordance with federal law and regulation, following state plans approved 
by the Centers for Medicare and Medicaid Services (CMS) within the federal Department 
of Health and Human Services.  The state plan details the categories of persons who will 
be eligible, including populations that are required to be covered, such as pregnant 
women and children and the elderly, and “optional populations” that the state may elect 
to serve.  Eligibility requirements refer to the federal poverty guidelines adopted annually 
by the federal Department of Health and Human Services.1   
 
 The state plan details the categories of medically necessary services that will be 
covered, including required services such as inpatient and outpatient hospital care, 
laboratory services, prenatal care, and periodic screening and check-ups for children.  
The plan designates certain optional services that the state elects to cover, such as 
prescription drugs, diagnostic and hospice services and eyeglasses.  Originally designed 
to provide services primarily in hospitals, physicians’ offices and nursing facilities, 
Medicaid has grown to cover more non-facility-based services, home and community-
based care and the largest single category of expenditures, prescription drugs. See Table 
1 for Medicaid acute care benefits and Table 2 for Medicaid long-term care benefits.  
Each state is required to convene a Medicaid advisory committee to participate in policy 
development and provide administrative oversight.  Other federal law and regulations 
impose additional requirements regarding eligibility, benefits, reimbursement, and 
program administration and operation.   
                                                 
1 The federal poverty guidelines are referred to informally as the “federal poverty level” or FPL.   
2005-2006 Federal Poverty Guidelines 
Persons in 
Family Unit 
100% fpl 135% 150% 185% 200% 250% 300% 350%
1 $9,570  $12,920  $14,355 $17,705 $19,140 $23,925  $28,710 $33,495 
2 $12,830  $17,321  $19,245 $23,736 $25,660 $32,075  $38,490 $44,905 
3 $16,090  $21,722  $24,135 $29,767 $32,180 $40,225  $48,270 $56,315 
4 $19,350  $26,123  $29,025 $35,798 $38,700 $48,375  $58,050 $67,725 
5 $22,610  $30,524  $33,915 $41,829 $45,220 $56,525  $67,830 $79,135 
Each additional 
person 
$3,260  $4,401  $4,890 $6,031 $6,520 $8,150  $9,780 $11,410 
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Table 1 
Medicaid Acute Care Benefits
“Mandatory” Items and Services
• Physicians services
• Laboratory and x-ray services
• Inpatient hospital services
• Outpatient hospital services
• Early and periodic screening, 
diagnostic, and treatment (EPSDT) 
services for individuals under 21
• Family planning and supplies
• Federally-qualified health center 
(FQHC) services
• Rural health clinic services
• Nurse midwife services
• Certified pediatric and family nurse 
practitioner services
“Optional” Items and Services*
• Prescription drugs
• Medical care or remedial care 
furnished by other licensed 
practitioners
• Rehabilitation and other therapies
• Clinic services
• Dental services, dentures
• Prosthetic devices, eyeglasses, 
durable medical equipment
• Primary care case management
• TB-related services
• Other specialist medical or remedial 
care
* These benefits are treated as mandatory for children under 21 through EPSOT in this analysis.
 
 
 
Table 2 
Medicaid Long-Term Care Benefits
“Mandatory” Items and Services
• Nursing facility (NF) services for individuals 
21 or over
“Optional” Items and Services*
• Intermediate care facility services for the 
mentally retarded (ICF/MR)
• Inpatient/nursing facility services for individuals 
65 and over in an institution for mental 
diseases (IMD)
• Inpatient psychiatric hospital services for 
individuals under age 21
Home & Community-Based Services
Institutional Services
• Home health care services (for individuals 
entitled to nursing facility care)
• Home and community-based waiver services
• Other home health care
• Targeted case management
• Respiratory care services for ventilator-
dependent individuals
• Personal care services
• Hospice services
• Services furnished under a PACE program
*These benefits are treated as mandatory for children under 21 through EPSDT in this analysis, with the 
exception of Home and Community based waiver services.
 
 
Medicaid waiver programs may be approved by CMS to waive certain federal 
requirements in order to allow the states to try new ways to deliver services, such as through 
managed care organizations, or to provide assistance to particular populations, such as 
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women with cervical cancer, persons with disabilities receiving care at home and persons 
with HIV/AIDS.   
 
2. Federal policy goals and program responsibilities 
 
Starting from the federal goal of providing necessary health care for certain low-income 
persons, the elderly and persons with disabilities, the states have flexibility to design their 
Medicaid programs in response to each state’s own health care needs, priorities and available 
funding.  States may set policy goals that cover more people or health care services.  
Reimbursement rates for health care service providers may be adjusted up or down by the 
state.  These rates, the timeliness of payment and the administrative requirements of the 
program affect the number of participating providers and access to care for members and 
thus also reflect the state’s policy goals for the program.   
 
B.  THE MAINECARE PROGRAM 
 
The Medicaid program in Maine, known as the MaineCare program, operates under the 
general policy statement of the Department of Health and Human Services, which is stated at 
Title 22-A, section 202:  “The mission of the department is to provide health and human 
services to the people of Maine so that all persons may achieve and maintain their optimal 
level of health and their full potential for economic independence and personal 
development.”  MaineCare relies on personnel within the Department of Health and Human 
Services Office of MaineCare Services (formerly the Bureau of Medical Services) to 
administer the program.  Office personnel respond to requests for information, develop rules 
and procedures, process claims, monitor compliance, train providers and address 
complaints.2  Eligibility determinations are handled within the Office of Integrated Access 
and Support within the department.  
 
Since 1998, Maine has adopted a number of policies that have expanded the number of 
persons eligible for MaineCare in order to reduce the number of people without health 
insurance.  Between 2000 and 2004 MaineCare rolls increased 2.7%, to over 260,000.3  
During that time period the percentage of uninsured nonelderly adults in Maine decreased 
1.1%4  placing Maine 5th in the nation in reducing the percentage of uninsured residents.5  In 
contrast, from 2000 too 2004 the number of uninsured nonelderly adults actually rose in all 
other New England states - in Connecticut by 2.1%, in New Hampshire by 3.6%, in Vermont 
by 3%, in Massachusetts by 3.2% and in Rhode Island by 4.2%.6  See Table 3.  Table 4 
provides information on mandatory and optional MaineCare beneficiary groups.   
 
                                                 
2 Statewide, overall coordination of health policy and health reform and assistance with prescription drug issues are 
provided by the Governor’s Office of Health Policy and Finance.   
3 “MaineCare, Annual Report to the State Legislature 2004,” pg 2, Department of Health and Human Services. 
4 Kaiser Commission on Medicaid and the Uninsured, State Medicaid Fact Sheet, Maine and the United States, 
December, 2005.  The number of uninsured nonelderly adults decreased by 7988 from 2000 to 2004. 
5 Kaiser Commission on Medicaid and the Uninsured, State Health Facts, 50 State Comparisons, “Percentage Point 
Change in Uninsured Among Nonelderly, 2000-2004.” 
6 “Health Coverage in America, 2004 Data Update,” page 13, Kaiser Commission on Medicaid and the Uninsured.   
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Table 3 
Percentage Change in the Uninsured Population 
 Connecticut Maine Massachusett
s 
New 
Hampshire 
Rhode 
Island 
Vermont 
2000-
2004 
+2.1% -1.1% +3.2% +3.6% +4.2% +3% 
 
 
Table 4 
MaineCare Beneficiary Groups 
Mandatory Populations Optional Populations 
Children under age 6, below 133%FPL Low-income children above 100% FPL, not 
mandatory by age 
Children age 6 and older, below 100% FPL  
Parents below 200% FPL Low-income parents with income at or below 
1996 AFDC level 
Pregnant women at or below 133% FPL Pregnant women above 133% FPL 
Elderly and disabled SSI beneficiaries at or 
below 77% FPL 
Elderly and disabled above SSI level but below 
100% FPL 
Certain working disabled adults Certain working disabled 
Medicare Buy-in groups (QMB, SLMB, QI) Medically needy 
 Nursing home residents above SSI levels but 
below 300% SSI 
 Persons at risk of needing nursing home or ICF-
MR care 
 
 
MaineCare coverage was expanded in 2003 through a waiver from CMS for adults with 
incomes below 100% FPL, $9570/year, who do not have minor children.  The population in 
this waiver is informally referred to as “noncategoricals.”  Implementation of this waiver 
brought with it unexpectedly heavy enrollment, utilization and expense, which exceeded 
projections of costs.  Rising to nearly 25,000 by March, 2005, noncategorical waiver 
coverage threatened to outspend the federally imposed spending cap and endanger the 
waiver’s federal matching funds.  After informing the Legislature, the Department of Health 
and Human Services responded in March, 2005 by freezing enrollment, so that enrollment in 
December, 2005 had dropped to 14,939.  Beginning in December, 2005, covered services for 
noncategorical adults were decreased from 54 services to just 18 services.   
 
The income and asset limits for financial eligibility for MaineCare are detailed in Table 
5.  Table 6 contains a listing of MaineCare services divided by preventive care, acute care, 
long term care, behavioral health and other services.  
 
 
 
 
 
 
Table 5 
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MaineCare Eligibility, 2005
Only covered for Medicare 
Part B premiums
$4,000/$6,000 per 
individual/couple
100-135% FPLSpecified Low-income Medicare 
Beneficiary/Qualifying Individual
$2,000/$3,000 per 
individual/couple
300% SSI standardDisabled in need of institutional 
care
$8,000/$12,000 per 
individual/couple
250% FPLWorking disabled
$2,000/$3,000 per 
individual/couple
100% FPLElderly & disabled
Enrollment suspended in 2005None100% FPLNon-Categorical Adults
$2,000 per unit200% FPLParents
12-month continuous eligibilityNone200% FPLCub Care (SCHIP) children
12-month continuous eligibilityNone150% FPLChildren (1-19 years)
12-month continuous eligibilityNone200% FPLInfants (< 1 year)
60-day post-partum eligibilityNone200% FPLPregnant women
NoteAsset Limit*Income LimitPopulation
* Some assets, such as a home, primary vehicle, and certain types of savings (including IRAs) are not counted.
 
Table 6 
MaineCare Services, 2005
•Pharmacy
•Transportation
•Medical supplies 
and durable 
medical 
equipment, 
eyeglasses, and 
orthotic and 
prosthetic devices
•Medicare Part B 
premium 
payments
•Institutional care 
(inpatient psychiatric 
services, intermediate 
care facilities for people 
with mental retardation)
•Community-based care 
(licensed social worker 
protective services, 
psychological services, 
day habilitation, day 
treatment, home and 
community based 
waiver services for 
people with mental 
retardation, community 
support, substance 
abuse treatment 
services)
•Institutional care 
(nursing facility and 
assisted living)
•Community-based 
care (private duty 
nursing, personal 
care, hospice, adult 
day health)
•Inpatient & outpatient 
hospital services
•Laboratory and x-ray 
services
•Physician, nurse 
practitioner services, and 
other advanced practice 
nursing services (also 
those provided in rural 
health clinics and 
federally-qualified health 
centers)
•Dental services
•Chiropractic services
•Ambulance services
•Podiatry services
•Occupational & physical 
therapy
•Speech, hearing, and 
language disorder services
•Early 
intervention 
(birth through 
age 5)
•Smoking 
cessation 
•Asthma and 
diabetes 
education
•Family 
planning 
services and 
supplies
•School-based 
rehabilitation
OtherBehavioral HealthLong Term CareAcute CarePreventive 
Care
  
 
1.  MaineCare’s role in the provision of health care 
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The MaineCare program provides health care services to certain low-income persons, the 
elderly and persons with disabilities.  The MaineCare program is at the hub of the state’s 
health care system, playing a central role in the provision of services to persons who are 
unable to afford care.   
 
♦ Providing health care coverage for 20% of Maine’s population, MaineCare keeps 
private health insurance premiums lower than they would be without MaineCare by 
covering many persons with disabilities and serious illnesses.   
♦ MaineCare provides coverage for health care services, including inpatient hospital 
care, that would otherwise be uncompensated care and bad debt. 
♦ MaineCare is the largest payor for long-term care services in the state, covering 
services in nursing facilities and home and community-based services.  These 
services are among the highest cost Medicaid services.   
♦ MaineCare pays consumers’ cost-sharing under Medicare and pays for prescription 
drugs.  Prescription drugs are a major cost-driver among MaineCare services, with 
outpatient prescription drug spending rising 13.2% in state fiscal year 2002, 17.7% in  
2003 and 10.9% in 2004.   
♦ Beginning in 2006 MaineCare will work with Medicare Part D to cover prescription 
drugs for persons who are elderly or disabled, shifting significant responsibilities to 
the Medicare Part D program.  MaineCare Commission members noted the need for 
attention as the Medicare Part D program begins operation.  They expressed concern 
about the possibility of gaps in coverage or increased costs for persons previously 
receiving drug benefits, the shift of costs out of MaineCare and the state “clawback” 
payment, a payment that is payable to the federal government to provide funding for 
the Part D benefit, which the Governor’s Office of Health Policy and Finance 
estimates will cost the MaineCare program an additional $11,000,000 in state funds 
between January and December, 2006. 
 
2.  MaineCare law and policy 
 
The benefits to the states of using federal funds to pay for necessary health care services 
have lead many states to a policy of maximizing the use of Medicaid.  As have other states, 
Maine has enacted laws and policies purposefully expanding MaineCare and the services it 
covers in order to decrease the number of uninsured persons.  In 2006 federal funds will pay 
close to $63 of every $100 of health care services under the MaineCare program.  MaineCare 
is then able spend $37 of state funds and buy nearly $100 of health care services.  
Particularly when a state is already paying for services with 100% state funds, federal 
funding participation is an attractive aspect of the Medicaid program.   
 
Maine has expanded MaineCare to cover previously state-paid services in the areas of 
targeted case management, school-based health care and residential care for children and 
adults with disabilities in private non-medical institutions. Expansion of programs in order to 
take advantage of the federal Medicaid match, a policy known as Medicaid maximization, 
has enabled Maine to expand access to services while providing partial federal funding.  
Maine has also instituted health care provider taxes on hospitals, nursing facilities, private 
non-medical institutions and residential treatment facilities.  These taxes are permissible 
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under federal law and result in increased MaineCare funding for the health care providers 
and revenue for the State. In addition to contributing funding for the states, provider taxes 
and the methodology for the match rate regularly controversy and political debate.  For a 
discussion of the federal funds rate methodology and issues, see section C, 2 and 3.   
 
Maine has elected to cover more persons and services under MaineCare than required by 
CMS, doing so under the state plan and any amendments to it and CMS approved waivers.  
MaineCare enrollees, known as “members,” include mandatory and optional populations 
covered through expansions that extend coverage to children under the State Children’s 
Health Insurance Program (SCHIP), formerly known in Maine as Cub Care, parents and legal 
guardians of minor children, and waiver programs for  the noncategoricals, persons with 
mental retardation receiving home and community-based care, persons with HIV/AIDS, 
women with breast and cervical cancer and persons with disabilities receiving care at home 
under the consumer-directed home care program.    Table 7 shows the MaineCare caseload 
by population category for July 2001 to November 2005. 
 
Table 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.  Services 
 
The array of MaineCare covered services, which must be medically necessary, remained 
stable through 2003.  In recent years some limits have been imposed on certain services for 
adults through the adoption of MaineCare Basic, under which the following services for 
adults are subject to limits: speech, occupational and physical therapy, rehabilitation 
services, psychological services, durable medical equipment, chiropractic services and 
services under the private duty nursing and personal care program and waiver programs.  In 
addition, noncategorical members are subject to the decrease in covered services from 54 to 
18 discussed above, are subject to limitations on inpatient and outpatient hospital visits and 
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brand name prescription drugs and are entitled to benefits from the date of acceptance into 
the program prospectively only.   
 
4.  Provider reimbursement 
 
In recent years, MaineCare reimbursement rates for providers have increased slightly for 
some providers, including dentists and physicians, while remaining unchanged for most 
providers.  The implementation of the MECMS claims management system for the payment 
of providers has presented very difficult challenges for MaineCare providers and the 
Department of Health and Human Services in 2005. 
 
5.  Co-payments and premiums 
 
Co-payments for MaineCare services are limited by federal law to nominal amounts and 
cannot be charged for services to pregnant women and children.  In MaineCare monthly 
premiums are allowed for SCHIP children’s coverage and for coverage under the waivers for 
Katie Beckett disabled children and working adults with disabilities. 
 
6.  Expenditures 
 
Total MaineCare expenditures, in state and federal funds, have increased from $1.1 
billion in 1998 to just over $2.0 billion in 2004, an average annual growth rate of 10.3%.  
Putting MaineCare’s expenditure growth into some context, during this same period 
Medicaid spending nationally grew at an average annual rate of 9.0%, while total personal 
health care spending in Maine - both public and privately funded - increased at rate of 7.5% 
per year.7  MaineCare spending has been driven by many of the same growth factors 
affecting other public and privately-funded health care spending (i.e., increases in health care 
costs, caseloads, and utilization of services).  However, in addition, Maine’s efforts to 
maximize the use of Medicaid for programs that previously were 100% state-funded have 
shifted certain expenditures from the General Fund to the MaineCare program.  While this 
has added to MaineCare’s budget growth it has also reduced the cost to the state for 
delivering the covered service from 100% General Fund dollars to 37% General Fund 
dollars.  MaineCare provider tax initiatives have also maximized the use of federal Medicaid 
funds.  Again, these initiatives have played a significant role in increasing total MaineCare 
expenditures, but they have enabled MaineCare to increase reimbursement to providers and 
to decrease reliance on General Fund dollars.  
 
Prescription drug costs have also been a major cost driver during this period, with state 
and federal spending increasing from $109.9 million in 1998 to $284.1 million by 2004, an 
average annual growth rate of 17.2%.8  In an effort to control these drug cost increases, a 
preferred drug list has been implemented, with access to non-preferred drugs through a prior 
                                                 
7 MaineCare expenditure data from “Understanding MaineCare: A Chartbook About Maine’s Medicaid Program,”  
By Rachel Garfield, January 2005, p. 24; National Medicaid data from the Centers for Medicare and Medicaid 
Services (CMS) data; and Maine total personal health care expenditures data from “Maine’s State Health Plan: A 
Road Map to Better Health,” (November 2005 Draft) p. 15 (derived from CMS data). 
8 “Understanding MaineCare: A Chartbook About Maine’s Medicaid Program,”  p. 28. 
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authorization process and exceptions for certain classes of drugs, certain populations and 
special medical conditions (assumed savings of $65.5 million per year by second year of 
implementation). The department also has begun voluntary mail-order for MaineCare 
members whose prescriptions do not change frequently (assumed savings of $14.4 million in 
first year of implementation). 
 
State-funded MaineCare spending also represents a significant and growing portion of 
the State General Fund budget, with its share of General Fund spending increasing during 
this period from 13.7% in 1998 to 20.1% by 2004.  See Table 8.    
 
Table 8 
MaineCare GF Spending's Share of State Total
1998 1999 2000 2001 2002 2003 2004
MaineCare and Related 
GF Spending $259.8 $382.6 $424.7 $449.9 $476.5 $500.7 $518.7
MaineCare GF 
Spending's Share of 
Total State GF Spending 13.7% 17.8% 18.3% 17.5% 18.4% 19.8% 20.1%
Source: 1999-2004 Data: OFPR MaineCare/Medicaid Funding History 12/8/2005
($'s in millions, state fiscal years)
 
 
MaineCare spending, by category of member served, follows national trends.  In 2004, 
children comprised 42.3% of the MaineCare population but accounted for just 22.2% of the 
spending, adults comprised 30% of the population and accounted for 11.7% of spending, and 
the elderly and persons with disabilities comprised 27.6% of the population and accounted 
for 66% of all expenditures.9  While seemingly disproportional, the high cost of serving the 
elderly and persons with disabilities reflects the expenses of long-term care and other 
residential services, prescription drugs, case management and disability support services.   
Table 9 shows a breakdown of MaineCare members by category of eligibility and the 
expenditures for each category.10   
 
 
 
 
Table 9 
 
 
 
 
                                                 
9 “Understanding MaineCare: A Chartbook About Maine’s Medicaid Program,”  p. 23. 
10 “MaineCare and Its Role in Maine’s Healthcare System,” p. 24, by Paul Saucier.  
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C.  MEDICAID – FINANCIAL CHALLENGES 
 
1.  Federal level financial projections 
 
The growth in Medicaid spending experienced in recent years is expected to continue. 
The Congressional Budget Office estimates an average 10 year growth rate of approximately 
7.8% for 2005-2015 and a likely range of growth rates for total Medicaid payments between 
7.1% and 9.6%.11  MaineCare Commission members agreed that with MaineCare growing 
faster than inflation the State needs to better manage MaineCare in order to produce 
accountability and predictability and to ensure the sustainability of the program.   
 
2.  Medicaid match rate  
 
Federal Medical Assistance Percentages (FMAPs), commonly referred to as the federal 
match rate, are used to determine the amount of Federal matching funds for State 
expenditures for medical assistance payments under Medicaid and for certain other social 
services.  The Social Security Act requires the U.S. Secretary of Health and Human Services 
to calculate and publish the FMAPs each year.   
 
Section 1905(b) of the Social Security Act specifies the formula for calculating Federal 
Medical Assistance Percentages.  "Enhanced Federal Medical Assistance Percentages" are 
used for the State Children's Health Insurance Program (SCHIP) under Title XXI of the 
Social Security Act. Section 2105(b) of the Social Security Act specifies the formula for 
calculating Enhanced Federal Medical Assistance Percentages. There is no specific 
requirement to publish the Enhanced Federal Medical Assistance Percentages, but they are 
included in the FMAP notice for the convenience of the states.   
 
                                                 
11 “Parameters for Long Term Growth in MaineCare Expenditures,” page 2, Maine Department of Health and 
Human Services, November 14, 2005.  The Congressional Budget Office provides 10 year estimates for federal 
expenditure programs, assuming Medicaid spending per enrollee over the next 10 years will grow .7% faster than 
per capita gross domestic product.  This rate is combined with a .9% growth in aggregate enrollment and the 
Congressional Budget Office baseline economic assumptions to estimate the likely 10 year growth rate.  
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The FMAPs are calculated using a formula based on each state’s relative per capita 
income, specifically, each state’s per capita income in relation to national per capita income.  
The intent of the formula is to narrow differences among states in their ability to fund 
Medicaid services by providing states with lower relative per capita incomes higher federal 
match rates and states with higher relative incomes lower federal match rates, subject to the 
limit that no state’s FMAP can be less than 50%.  Relative per capita income is measured 
based on the latest three years of per capita income data as measured by the U.S. Department 
of Commerce, Bureau of Economic Analysis (BEA).  For example, the FMAPs for federal 
fiscal year 2006, which began on October 1, 2005, were published in the fall of 2004 based 
on per capita income data for calendar years 2001, 2002, and 2003.  As indicated in Table 10 
below, in recent years, Maine has been experiencing a significant decline in its FMAPs.12 
Table 1013 
                                             Maine's Medicaid Match Rates
Medicaid 2002 2003 2004 2005 2006
Federal 66.58% 66.22% 66.01% 64.89% 62.90%
State 33.42% 33.78% 33.99% 35.11% 37.10%
Federal 76.61% 76.35% 76.21% 75.42% 74.03%
State Child Health 
Insurance Program 
(SCHIP)
 
3.  FMAP issues 
The MaineCare Commission reviewed a report entitled Project Report: The Impact of the 
Federal Medical Assistance Matching Formula in Maine (Chuck Lawton, Planning 
Decisions, Inc., 2005) that in addition to providing background information on the FMAP, 
identified three problems with the FMAP as a measure of each state’s relative ability to fund 
its Medicaid program: (1) the time lag inherent in the FMAP formula (e.g., 2001, 2002, 2003 
data used for federal fiscal year 2006); (2) the inadequacy of relative per capita personal 
income as a measure of state fiscal capacity; and (3) the failure of relative per capita income 
to capture each state’s demographic structure, particularly the relative number of elderly and 
disabled persons, which is a significant cost driver for state Medicaid programs. 
During the MaineCare Commission’s discussion of this issue, it was noted that Senator 
Snowe has introduced a bill regarding the FMAP formula but that reform at the federal level 
this year is uncertain because the debate in Congress would pit states against each other 
unless additional money were made available so that no state would be negatively affected 
                                                 
12  As a rule of thumb, assuming a $2 billion MaineCare program, a 1% change in the FMAP results in an 
approximate shift of $20 million in spending between Maine and the federal government. 
13  For the five quarter period from April 2003 through June 2004, the federal Jobs and Growth Tax Relief and 
Reconciliation Act of 2003 provided a one-time increase in FMAPSs.  For Maine, the increase was approximately 3 
percentage points above the FMAP amounts shown above for the period. 
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by an FMAP formula change.14  In his presentation to the MaineCare Commission, Governor 
King expressed a similar concern about the difficulty in making FMAP formula changes, 
noting the federal Medicaid Commission specifically decided not to consider 
recommendations regarding changes to the FMAP. 
4.  Financial challenges for the MaineCare program 
 
As discussed in part B of this report, growth in Medicaid expenditures has exerted 
significant fiscal pressures on the State General Fund budget, particularly when that growth 
has outpaced revenue for the State, and as a result MaineCare’s share of total General Fund 
spending continues to increase.  This trend is expected to continue. Table 11 includes 
preliminary estimates of state General Fund MaineCare spending through the 2008-2009 
biennium.   
Table 11 
2004 2005 2006 1 2007 1 2008 2009
MaineCare and Related 
GF Spending $518.7 $595.2 $619.7 $624.6 $723.1 $771.5
MaineCare GF 
Spending's Share of 
Total State GF 20.1% 21.7% 22.0% 21.8% 22.9% 23.3%
Source: 2004-2007 Data: OFPR MaineCare/Medicaid Funding History 12/8/2005
              2008-2009 Structural Gap Preliminary Estimates: OFPR Budget Overview 7/1/2005
1   MaineCare 2006 and 2007 appropriations adjusted to "smooth out" the impact of making all hospital 
lawsuit settlements in 2006
($'s in millions, state fiscal years)
MaineCare General Fund Spending's Share of Total General Fund -- Estimated
Budgeted
OFPR  Preliminary 
Estimate
 
 
 
While MaineCare-specific longer term cost projections do not currently exist, recent 
trends suggest growth at or above the Congressional Budget Office’s national average annual 
10 year growth rate of approximately 7.8%, is likely. The Department of Health and Human 
Services has begun to work in earnest on 5 and 10-year projections of MaineCare 
expenditures.  Commission members expressed interest in economic forecasting for the 
MaineCare program and await further word on the results of this initiative. 
 
D.  FEDERAL MEDICAID COMMISSION 
 
1.  Overview 
 
                                                 
14  As referenced in the Federal Medicaid Commission section of this report, the Senate–passed version of the 2005 
federal budget reconciliation bill included an amendment giving fiscal relief to states experiencing reductions in 
their 2006 FMAPs.  The House-passed bill did not include this language and its fate is uncertain in conference. 
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On May 19, 2005, the Secretary of the U.S. Department of Health and Human Services 
established the federal Medicaid Commission to advise the Secretary on ways to modernize the 
Medicaid program so that it can provide high-quality health care to its beneficiaries in a 
financially sustainable way.  The federal Medicaid Commission was a product of the debate over 
the FY 2006 Congressional Budget Resolution’s provisions requiring Medicaid program savings. 
 
The Secretary selected the former governor of Tennessee, the Honorable Don Sundquist 
as the Chair of the Commission and the former governor of Maine, the Honorable Angus S. 
King, Jr., as the Vice-Chair.  The federal Medicaid Commission was to include up to 15 voting 
members (with 13 having been appointed to date) and 15 non-voting members. 
 
The federal Medicaid Commission was tasked with two specific charges: 
 
1.  Report to the Secretary by September 1, 2005 on options to achieve $10 billion in 
“scorable” Medicaid savings over 5 years while at the same time making progress toward 
meaningful longer-term changes to better serve beneficiaries. 
2.  Report to the Secretary by December 31, 2006 with longer-term recommendations on 
the future of the Medicaid program. 
2.  Short-Term Report 
After meeting during the summer of 2005, including two public meetings, and receiving 
testimony from a broad array of governmental and non-governmental concerned parties, the 
federal Medicaid Commission released its short-term report making recommendations to achieve 
$11 billion in “scorable” savings to the Medicaid program over 5 years.15 Governor Angus King 
noted in his testimony before the MaineCare Commission that $11 billion in savings would 
reflect slowing the growth rate from 7.4% to 7.2%.16  Table 12 below summarizes the Federal 
Medicaid Commission short-term recommendations.17  The full report of the federal Medicaid 
Commission is included as Appendix C. 
 
 
                                                 
15  In his presentation to the Maine Blue Ribbon Commission on the Future of MaineCare, Governor King noted the 
federal Medicaid Commission specifically decided not to consider recommendations regarding the Medicaid match 
rate (i.e., the Federal Medical Assistance Percentage or FMAP) 
16 Governor Angus S. King, Jr., testimony before the Blue Ribbon Commission on the Future of MaineCare, 
November 15, 2005. 
17  With regard to the savings estimates noted in the table, the proposals may interact with each other, causing a 
reduction in savings of up to $200 million. 
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Table 12  
Summary of Federal Medicaid Commission Short-term Recommendations 
 
Subject 
 
Recommendation 
Estimated 
savings / 5 
years 
Prescription Drug 
Reimbursement 
Formula 
Allow states to establish prescription drug prices based on Average 
Manufacturer Price (AMP) rather than Average Wholesale Price 
(AWP) and implement reforms to ensure that manufacturers 
appropriately report data. 
$4.3 billion 
Prescription Drug 
Rebates in Medicaid 
Managed Care 
Allow Medicaid managed care health plans access to the drug 
manufacturer rebate program, giving states the option of collecting 
the rebates or the managed care plan collecting the rebates and being 
paid a lower capitation rate.  (Maine does not have Medicaid 
managed care.) 
$2.0 billion 
Estate Transfer  
Penalty Period 
With respect to eligibility for nursing facility care, move the start date 
for the penalty period for non-allowed transfers from the date of 
transfer to the date of application for Medicaid or the date of nursing 
facility admission, whichever is later. 
$1.4 billion 
Estate Transfer  
“Look-back” Period 
With respect to eligibility for nursing facility care, increase from 36 
to 60 months the “look-back” period, during which transfers of assets 
may disqualify an applicant for care. 
$100 million 
Co-payments for 
Prescription Drugs 
Allow states to develop tiered co-payment structures to encourage 
cost-effective drug utilization.  Allow states to increase co-payments 
on non-preferred drugs above the nominal amount when a preferred 
drug is available. Retain nominal co-payments for persons below the 
poverty level. Require co-payments for preferred drugs to be 
enforceable.  Allow states to waive co-payments for true hardship or 
when failure to take a non-preferred drug might create serious 
adverse health effects.   
$2.0 billion 
Medicaid Managed 
Care Organizations 
provider taxes 
Reform health care provider tax law for Medicaid managed care 
organizations so that they are treated like all other health care 
providers - uniformity among providers and no guarantee of return to 
the provider of taxes paid. (Maine does not have Medicaid managed 
care.) 
$1.2 billion 
 
3.  Status of Short-Term Recommendations 
Given the federal Medicaid Commission had its origins in the Congressional budget 
process, specifically the FY 2006 Congressional Budget Resolution, the initial fate of these 
recommendations will be determined in the currently pending legislation to implement the 
Budget Resolution – a so-called reconciliation bill – titled the Deficit Reduction (Omnibus 
Reconciliation) Act of 2005. 18 
The Senate passed its version of the reconciliation bill (S. 1932) on November 3, 2005.  
The Senate-passed bill includes $34.6 billion in net “savings” to entitlement/mandatory 
                                                 
18  As part of the congressional budget process established in 1974, the annual Congressional Budget Resolution 
establishes the framework for determining the annual federal budget.  The details of the federal budget are then 
enacted in annual appropriations bills and when required, a so-called reconciliation bill, making statutory changes in 
mandatory/entitlement programs. 
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programs over five years, including $4.3 billion in Medicaid program net “savings” over five 
years.19 
The House passed its version of the reconciliation bill (H.R. 4241) on November 18, 
2005.  The House-passed bill includes just under $50 billion in net “savings” to 
entitlement/mandatory programs over five years, including $8.9 million in Medicaid program net 
“savings” over five years.20 
A conference committee will attempt to resolve differences between the two bills in 
December.  At this point it is difficult to predict what the outcome of the conference committee 
will be. However, some of the federal Medicaid Commission’s short term recommendations, 
along with some of a similar set of proposals made by the National Governor’s Association,21 are 
reflected in some form in either the House or Senate bills.  The National Governor’s Association 
report is included as Appendix D.  An outline of the report is included as Appendix E.   
4.  Longer-Term Report 
The second charge of the federal Medicaid Commission is to submit a report to the 
Secretary of the U.S. Department of Health and Human Services by December 31, 2006, making 
longer-term recommendations on the future of the Medicaid program that ensure the long-term 
sustainability of the program. The federal Medicaid Commission was further directed to develop 
proposals that address the following issues: 
 
1. Eligibility, benefits design, and delivery; 
2. Expanding the number of people covered with quality care while recognizing 
budget constraints; 
3. Long term care; 
4. Quality of care, choice and beneficiary satisfaction; 
5. Program administration; and 
6. Other topics that the Secretary may submit to the Commission. 
 
The federal Medicaid Commission met on October 27 and 28, 2005, to begin 
consideration of phase 2 of its charge. The federal Medicaid Commission received presentations 
on the defined issues that comprise the second charge and is expected to continue its 
deliberations over the next year to meet the December 31, 2006 reporting deadline.  
 
E.  STATE MEDICAID POLICY INNOVATIONS 
 
The MaineCare Commission reviewed key types of policy innovations in state Medicaid 
programs across the nation.  The foundation for this review was provided by Neva Kaye, Senior 
Program Director, The National Academy for State Health Policy, in a presentation to the 
MaineCare Commission on November 1, 2005.  
  
                                                 
19  The Senate-passed bill’s $4.3 billion net Medicaid savings assumption over five years reflects $2.1 million in FY 
2006 net spending increases offset by $6.4 million in net savings over the FY 2007-2010 period.  
20  The House-passed bill’s $8.9 billion net Medicaid savings assumption over five years reflects $2.1 million in FY 
2006 net spending increases offset by $11 million in net savings over the FY 2007-2010 period. 
21 “Short-Run Medicaid Reform,” National Governors Association, August 29, 2005.   
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1.  Medicaid policy innovations in managed care 
The MaineCare Commission reviewed information regarding innovation in managed care 
provided by Ms. Kaye and information specific to Maine provided by representatives of the 
Department of Health and Human Services. 
 
A.  National policy innovations in managed care 
 
1) Traditional Managed Care.  Nearly all state Medicaid programs have implemented 
managed care programs as a strategy to manage costs and improve care.  There are three 
key models of managed care used by state Medicaid programs:  (1) comprehensive 
Medicaid managed care organizations (MCOs) that assume financial risk for the delivery 
of services to beneficiaries in exchange for a fixed monthly payment per enrollee; (2) 
prepaid plans, including prepaid inpatient health plans and prepaid ambulatory health 
plans, that assume financial risk for a portion of services (for example, behavioral 
health), in exchange for a fixed fee; and (3) primary care case management (PCCM) 
programs that pay participating providers a monthly case management fee to coordinate 
and monitor health care services for enrollees.  As of June 2004, all but 3 states (AK, NH, 
WY) had managed care programs in place for their Medicaid enrollees, and 60% of 
Medicaid beneficiaries nationwide were enrolled in some form of managed care.22 
 
2) Managed Behavioral Health Care.  Managed behavioral health care under Medicaid 
may be (1) integrated with an MCO (described above) or (2) implemented as a “carve 
out” in which behavioral health services are contracted for separately from medical 
benefits.  One option under the “carve out” approach is to contract with a public or 
private managed behavioral health organization (BHO) that specializes in mental health 
and substance abuse.  In 2004, 41 states delivered mental health services to Medicaid 
beneficiaries through managed behavioral health care.  
 
3) Disease Management.  Disease management (DM) programs are designed to lower 
health care costs and improve health outcomes for individuals with chronic health 
conditions through enhanced coordination of care, treatment monitoring, patient 
education, and adherence to best practices.  DM programs typically target individuals 
with specific diagnoses, such as asthma, diabetes, cardiovascular disease, hypertension 
and depression. CMS has endorsed disease management under Medicaid.23  CMS 
identifies 3 key DM models for use under Medicaid: (1) DM through contracting with a 
disease management organization; (2) DM through an enhanced PCCM program in 
which providers deliver DM services, typically for an enhanced PCCM fee; and (3) DM 
through individual fee-for-service (FFS) providers in the community.   
 
4) Pay-for-Performance.  Pay-for-performance refers to a health care purchasing strategy 
that rewards providers for meeting specific measurable performance standards, with the 
goal of advancing the quality of health care services.24  Data collection and measurement 
                                                 
22 “State Health Facts, 50 State Comparisons,”  Kaiser Commission on Medicaid and the Uninsured, June 30, 2005. 
23 Centers for Medicare and Medicaid Services, State Medicaid Director Letter 04-0002. 
24 “CMS Pays for Performance Programs,” Terris A. King, July 15, 2005. 
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of provider performance is critical to this strategy.  Performance incentives may include: 
financial rewards, financial penalties and non-financial incentives, such as public 
presentation of performance data.25  In recent years, a handful of state Medicaid programs 
have begun to implement pay-for-performance, most often as part of Medicaid managed 
care contracts.  In California, the Local Initiative Rewarding Results program applies 
pay-for-performance to the Medi-Cal (Medicaid) and Healthy Families (SCHIP) 
programs. 
 
B.  MaineCare managed care initiatives.  MaineCare has undertaken a number of initiatives 
in managed care that the MaineCare Commission recommends continuing, with renewed 
commitment, dedication of personnel and focus.  
 
1) Primary Care Case Management.  Maine has implemented primary care case 
management, with the following goals: increasing access to primary care, promoting 
preventive care, reducing episodic care, controlling chronic conditions and reducing 
health care costs. In 2004, approximately 163,000 MaineCare members were enrolled in 
PCCM (62% of all members).  Currently, PCCM is required for MaineCare members 
who receive TANF benefits, are in families with minor children, are SCHIP members, or 
are covered under the noncategorical adult waiver.   
 
Elderly and disabled MaineCare members are not eligible for MaineCare PCCM. This is 
in contrast to most states in which some or all elderly and disabled Medicaid 
beneficiaries are enrolled in a managed care program.   
 
Under the PCCM program, the MaineCare enrollee has a primary care physician (PCP) 
who provides a “medical care home” and manages and coordinates care for the member.  
MaineCare pays participating PCPs a nominal fee per member per month for their case 
management responsibilities. The PCCM program also includes a pay-for-performance 
component, the Primary Care Physician Incentive Program (PCPIP).  Under PCPIP, 
participating PCPs are tracked for quality indicators and receive regular performance 
reports, and MaineCare pays an incentive payment to those PCPs ranked above the 20th 
percentile on specified performance measures within their primary care specialty.  
Examples of performance criteria include emergency room utilization rates, admission 
rates for avoidable hospitalizations, lead screening rates and mammogram rates.  
 
The experience of primary care case management is promising.  In 2004 98% of 
MaineCare children ages 12-24 visited their primary care providers, 79% of women ages 
21—64 had their annual PAP tests and 71% of MaineCare members with diabetes had 
their HbA1c tests.26 
 
                                                 
25 “Are Incentives Effective in Improving The Performance of Health Care Plans,” pg 6, by Mary Beth Dyer, March 
2002. 
26 “MaineCare Landscape,” Department of Health and Human Services presentation to the Blue Ribbon 
Commission on the Future of MaineCare, November 1, 2005.  
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2) Managed Behavioral Health Care.  Maine is currently in the process of planning a 
managed behavioral health care program pursuant to Public Law 2005, chapter 457, Part 
PP.  The program will provide comprehensive mental health and substance abuse services 
and will be implemented as a “carve out” for all MaineCare beneficiaries.  The law 
requires that the program be implemented through a contract with an organization with 
demonstrated success in managed care for behavioral health services.  Responsibilities of 
the managed care organization will include: contracting with providers, credentialing and 
quality assurance, utilization review, coordination of care, data collection and reporting. 
The law deappropriates $10.4 million from the state General Fund in state fiscal year 
2006-2007 for savings to be achieved by implementing the managed behavioral health 
care program and, in the event that savings are not realized, requires DHHS to inform the 
Legislature of alternative proposals to achieve the savings. 
 
Next steps in development and implementation of the managed behavioral health care 
program include: development of a statewide behavioral health plan; an actuarial study of 
mental health and substance abuse expenditures; preparation of a state plan amendment 
or waiver application to CMS; and contracting with a managed care organization. 
 
3) High Cost Member Pilot Program.  Maine is planning a pilot program for high cost 
members that will incorporate aspects of primary care case management and pay for 
performance and serve the approximately 300 members with annual expenditures from 
$30,000 to $100,000.  Participants will be assigned a “nurse care manager” whose 
responsibilities will include patient education, assisting the member and the member’s 
health care providers in the development of an individual care plan, promoting 
compliance with the care plan, linking the member to community resources and 
coordinating the member’s care.  In addition, each participant will be linked with a PCP 
who will provide a “medical care home” as described above.  The state plans to provide 
an enhanced PCCM fee to PCPs for high cost member pilot participants to reflect the 
expectation of enhanced case management responsibilities, including working with the 
nurse care manager, reviewing all prescriptions and durable medical equipment 
purchases and coordination of relatively complex care needs. In addition, participating 
PCPs will receive additional financial incentives based on performance outcomes (pay-
for-performance). The state has issued an RFP for nurse care management services and 
received five bids and plans to begin program implementation in early 2006. 
 
C.  MaineCare Commission support for managed care innovations.  MaineCare 
Commission members support the following innovations with regard to managed care in 
MaineCare and offer these recommendations: 
 
1) Expand PCCM and PCPIP to cover more persons, specifically to include persons with 
chronic health conditions who could be served through disease management and the 
elderly, persons with disabilities and other persons with high cost care. 
2) Integrate physical health services and behavioral health services, including substance 
abuse services, for adults and children, while managing the funding of those services. 
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3) Anchor MaineCare’s managed care initiatives in a commitment to provide high quality 
service to members, substituting lower-cost community-based care for higher cost 
institutional based care. 
4) Administer and implement all managed care initiatives to achieve their policy goals, 
budgeting to achieve the budget developed for the initiatives and dedicating personnel 
and resources to ensure adequate administrative capacity and success.   
5) Utilize the Maine Health Data Organization all claims database in the management of 
MaineCare programs, including use for managed care, quality assurance and 
administrative purposes. 
6) Proceed slowly to consider pay-for-performance, recognizing the need for reliable data 
and quality measures and integrating any initiative with changes in provider 
reimbursement, PCCP and PCPIP.   
 
2.  Medicaid policy innovations in program management  
The MaineCare Commission reviewed information regarding innovations in program 
management provided by Ms. Kaye and information specific to Maine provided by 
representatives of the Department of Health and Human Services. 
 
A.  National innovations in program management 
1) Selective contracting.  Selective contracting refers to a strategy in which a state 
Medicaid program contracts with a restricted set of providers chosen through a 
competitive bidding process to provide certain Medicaid services.27  Selective contracting 
requires several federal waivers, including a waiver to limit a beneficiary’s choice of 
health care providers, and a waiver to award contracts based on methodologies other than 
Medicaid’s cost-based principles.  State Medicaid programs have used selective 
contracting for a range of services including inpatient care, nursing home care, medical 
transportation services and eyeglasses, but this approach is not widespread. 
 
2) Consumer empowerment initiatives.  In recent months, two states-Iowa and Florida-
have received CMS approval for Section 1115 waivers to implement Medicaid reform 
programs that incorporate the principles of consumer empowerment and personal 
responsibility for health.  By incorporating these principles into Medicaid, the states aim 
to improve the health of Medicaid enrollees and, as a result, reduce costs.  Under Iowa’s 
expansion program, enrollees will be required to pay a monthly premium.  To provide 
incentives for healthy behavior, the state can reduce the premium if the enrollee engages 
wellness activities, such as smoking cessation or compliance with a personal health 
improvement plan. Under Florida’s Medicaid reform program, enrollees who engage in 
specified wellness activities will accumulate “healthy behavior credits”, with cash value, 
in an “enhanced benefit account” that the enrollee can use for out-of-pocket medical 
expenses.28 
 
B.  Maine innovations in program management 
                                                 
27 “Strategy 10, Selective Contracting,”  page 1, National Conference of State Legislatures, 2005. 
28 Florida Medicaid Reform, 1115 Waiver Application,  pg 3; “State Medicaid Actions,” Health Policy Tracking 
Service, September 20, 2005.  
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The MaineCare program does not include any program management innovations in selective 
contracting  or consumer empowerment. 
 
C.  MaineCare Commission comments regarding program management innovations.  
MaineCare Commission members did not endorse these program management options but offer 
the following comments: 
 
1) Selective contracting could perhaps provide options for a new model of managed care to 
benefit the program and members.  Selective contracting should be carefully scrutinized 
to ensure that it does not limit access, create a 2-tiered system, or interfere with choice, 
quality of service, existence of a provider network and provider capacity. 
2) Consumer empowerment innovations, which impose responsibilities on Medicaid 
enrollees for their health related behaviors have not been operating long enough to 
produce data on their effects.  Data is needed on the effect of these initiatives on 
consumer behavior, access to services and health.  Commission members expressed 
concern that MaineCare members could take more responsibility for their health and their 
care, that consumers with so little income and assets should not take on risk and that 
safety net providers could ultimately bear the burden of providing free care as an 
unforeseen consequence. 
 
3.  Medicaid policy innovations regarding private health coverage 
The MaineCare Commission reviewed information regarding innovations regarding private 
health coverage provided by Ms. Kaye and information specific to Maine provided by 
representatives of the Department of Health and Human Services. 
 
A.  National innovations 
1) Leveraging Employer Health Insurance / Premium Assistance Programs.  Premium 
assistance programs subsidize the purchase of private, employer-sponsored health 
insurance by low-income individuals and families using federal and state Medicaid or 
SCHIP funds.  The 2001 Health Insurance Flexibility and Accountability (HIFA) section 
1115 waiver initiative has promoted the adoption of premium assistance programs by 
states.29  The design of premium assistance programs varies state-to-state with respect to 
employer contribution requirements, enrollee contribution requirements, wraparound 
coverage for Medicaid benefits and excess cost sharing and measurement of cost-
effectiveness.30  Depending on how the program is structured it may be done with a state 
plan amendment or may require a waiver from CMS. 
 
B.  MaineCare initiative regarding private health coverage. 
 
1)  Private Health Insurance Premium Program.  Maine enacted a premium assistance 
program known as the Private Health Insurance Premium Program (PHIPP) in 1998.31 
                                                 
29 “Premium Assistance Programs: How Are They Financed and Do They Save States Money,” pg 1, Kaiser 
Commission on Medicaid and the Uninsured, October, 2005 
30 “Premium Assistance Programs: How Are They Financed and Do They Save States Money,” pg 14, Kaiser 
Commission on Medicaid and the Uninsured, October, 2005. 
31 22 MRSA section 18. 
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Under PHIPP, MaineCare will subsidize enrollment in a private group health plan for an 
individual who is otherwise eligible for MaineCare if the state determines it is cost-
effective.  The law defines “cost effective” as the expected reduction in MaineCare 
expenditures as a result of enrollment in the group health plan being greater than the 
expected additional expenditures required by the state to provide wrap-around coverage, 
meaning any premiums, deductibles, coinsurance and cost-sharing requirements of the 
group health plan for services otherwise covered under MaineCare. 
 
Current enrollment in PHIPP has been very low, 120 cases, involving a total of 200 
individuals.  DHHS has started to explore the reasons for low participation and potential 
strategies to increase participation. Resolves 2005, chapter 9, passed earlier this year 
requires DHHS to report by January 15, 2006, to the Health and Human Services 
Committee and the Insurance and Financial Services Committee on the status of the 
PHIPP, including information about payments made under the program, premiums and 
the carriers to which they are paid and savings achieved by the department.  The resolve 
authorizes the 2 committees to report out legislation related to the report.  
 
C.  MaineCare Commission comments on innovations regarding current private health 
coverage.  MaineCare Commission members endorse the current private health insurance 
premium program and believe that increased enrollment may be possible, bringing increased 
partnership with private health coverage and savings for the MaineCare program.  They await 
the report in January, 2006, from the Department of Health and Human Services to the Joint 
Standing Committee on Health and Human Services and the Joint Standing Committee on 
Insurance and Financial Services.   
 
MaineCare Commission members expressed interest in the Long-term Care Partnership Program, 
which enables persons who purchase and make use of long-term care insurance to shelter certain 
assets and qualify for the Medicaid program.  The National Governors Association report “Short-
Run Medicaid Reform” suggests that federal laws be changed to allow more states to participate 
in the Long-term Care Partnership Program, that states have flexibility in qualifying policies for 
approval and that nationwide standards on asset protection be adopted.32 
 
 
 
 
III.  FINDINGS AND RECOMMENDATIONS 
 
The MaineCare Commission makes the following findings and recommendations and 
notes ongoing issues confronting the MaineCare program for future consideration.  In addition 
the MaineCare Commission voted to request legislative approval for reauthorization of the 
MaineCare Commission to work after the 2006 legislative session.  MaineCare Commission 
members are interested in working together to review Medicaid developments on the federal 
level and their implications for Maine and to discuss implementation of the MaineCare portions 
                                                 
32 “Short-Run Medicaid Reform,”  pg 5. 
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of the supplemental budget and the list of policy issues for further consideration regarding the 
MaineCare program.   
 
A.  Findings 
 
1. MaineCare plays a critical role in the overall health care delivery system in Maine by 
providing coverage to many persons with disabilities or other serious health conditions, 
the majority of long-term care services, and other medically necessary services to low-
income families and individuals who would otherwise be uninsured.  Any program 
changes must be made carefully with consideration of the impact that those changes 
would have on the overall health care system.   
 
2. The Commission finds that state and federal law provide only limited policy direction for 
the Medicaid program.  Further, the Commission finds that due to the lack of policy 
direction and in the absence of program goals and management focused on those goals, 
MaineCare has fallen into a pattern of policy-making that is driven by fluctuations in the 
state budget. 
 
3. The Commission finds that MaineCare health care spending, like all health care 
spending, has been increasing faster than inflation, that it comprises 20% of the state 
budget, and that the State needs to better manage MaineCare in order to contain costs and 
produce accountability and predictability and to ensure the sustainability of the program. 
 
4. The Commission recognizes and commends the Department of Health and Human 
Services for designing and implementing new initiatives that will provide better services 
to MaineCare members and slow the rate of growth of expenditures and for beginning the 
planning for other initiatives, such as managed behavioral health care.  The Commission 
notes the challenges that change brings to such a large program that serves a critical role 
in Maine’s health care system.  The Commission finds that attention to Medicaid issues is 
needed on state and national levels.  In particular, the Commission notes that federal 
Medicaid program changes are under consideration as this report is being prepared and 
that the second phase recommendations of the federal Medicaid Commission are 
expected late in 2006.   
 
 
 
B.  Recommendations 
 
1. The Commission recommends that the federal Medicaid Commission review and make 
recommendations to alter the methodology for calculating the federal medical assistance 
percentages (FMAP) so that the methodology does not contain a time lag, represents a 
better measure of state fiscal capacity and captures each state’s demographic structure. 
 
2. In the further implementation of managed care in MaineCare the Commission 
recommends that the Department of Health and Human Services apply primary care case 
management to a broader population, particularly to the elderly and persons with chronic 
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conditions and disabilities as well as focusing on individuals with high cost care.  The 
Commission recommends that the initiative be anchored in a commitment to high quality 
services to members, substituting lower cost community-based care for higher cost 
institutional based care. 
 
3. In planning and implementing managed behavioral health care benefits as authorized by 
Public Law 2005, Chapter 457, the Commission recognizes that the initiative will 
capitate behavioral health financing only, and urges the department to adopt best practice 
for integrating capitated behavioral health services with physical health services, and that 
it apply to adults and children. 
 
4. The Commission recommends utilizing the Maine Health Data Organization all claims 
database in the management of the MaineCare program, including use for managed care, 
quality assurance and administrative purposes. 
 
5. With regard to all MaineCare initiatives and waivers, the Commission recommends that 
the program be guided by clear policy, that goals be established to achieve that policy, 
that realistic budgets be developed to meet those goals, and that fiscal management be 
applied so that the program delivers high quality services in partnership with service 
providers and remains within budget.  In managed care initiatives, the Commission 
recommends that the goals be integration of health care and management of the funding 
of those services. This recommendation requires the allocation of personnel and 
resources to ensure adequate administrative capacity and success.  In addition, it 
envisions a new level of accountability within the program.   
 
6. The Commission endorses the current private health insurance premium program and 
believes that increased enrollment may be possible, bringing increased partnership with 
private health coverage and savings for the MaineCare program.   
 
7. The Commission recommends that the Legislature review incentives for the purchase of 
long-term care insurance, which must be viewed within the context of any federal 
restrictions and requirements.    
 
8. The Commission supports the incorporation of new technologies that create efficiencies 
or decrease costs, particularly electronic medical records.   
 
9. The Commission recommends that action be taken to provide immediate professional 
leadership for the Department of Health and Human Services and major offices within 
the department.  The new leaders must have vision, skills and experience to provide the 
MaineCare program with staffing, an internal evaluation component and long-term 
planning so that stability, predictability and accountability may be achieved.   
 
C.  Policy issues for further consideration regarding the MaineCare program 
 
1. Simplification of federal program eligibility rules, focusing on income level and 
replacing the categories of eligibility now used. 
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2. Consideration of the role of private market forces, including private health insurance and 
health savings accounts. 
 
3. Review of options for financing long-term care, including incentives for the purchase of 
long-term care insurance. 
 
4. Resolution of the implementation problems with MECMS provider payment system. 
 
5. Resolution of the issue of timely payments to hospitals for MaineCare services.   
 
6. Consideration of the role of member co-payments, including the effect of mandatory and 
voluntary co-payments on the member, the provider and the program. 
 
7. Management of the noncategorical adult waiver to ensure access to and maximization of 
coverage.   
 
8. Consideration of the Medicare Part D drug program and its impact on MaineCare and 
related recipients, and the state budget. 
 
9. Review of the results of implementation of the State Health Plan. 
 
10. Review of federal application of prescription drug pricing based on Average 
Manufacturer Price, with state flexibility on dispensing fees, and the effect on access to 
prescription drugs. 
 
11. Review implementation of the development by the Department of Health and Human 
Services of models to better analyze and forecast program trends and growth rates. 
 
12. Clarification of the roles of the Department of Health and Human Services, Office of 
MaineCare Services and the Governor’s Office of Health Policy and Finance in the 
development and implementation of MaineCare policy. 
 
13. Monitoring of the number of uninsured persons in the State, considering the costs of 
health care and health insurance and the role of MaineCare. 
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Introduction 
Purpose of the Commission 
The Medicaid Commission was established by charter by the Honorable Michael 0. Leavitt, 
Secretary of the United States Department of Health and Human Services, in May 2005. The 
commission charge is defined as follows: 
a) The Commission shall rcpon to lhe Secretary. for his considcrat,on and submission to 
Congrcs~. by September I. 2005, their recommendations on options to achieve $ 10 billion in 
scorablc Medicaid savings over 5 years wh ilc at the same time make progress toward 
mcaningful longcr-tenn program changes to better serve beneficiaries. 
b) 13y December 31, 2006, the Commissior1 shall submit to the ScCI'clllry a report muking 
longcr-tcnn recommendations on the future of the Medicaid program that ensure the loog-
tcrm sustainnbi lity of the progrnm. They shall develop proposals that address the followi11g 
is~uc~: 
I) Eligibility, bene li t:; design. and delivery: 
2) Expanding the number of p~oplc covered wrth quality care whi le rccogni/.ing hudgct 
i.:Ons traints; 
3) Long tenn care: 
4) Quality of care. choice and benefi ciary satisfaction; 
5) Program administration; and 
6) Other topics that the Secretary may subnur to the Conunission. 
The Medicaid Program Today 
tvledicaid is a program that pays for medical as'Sistance for cerrain individuals and fami lies with 
low incomes and resources. The program became law in 1965 and is jointly fimded by the 
Federal and state governments (including the District of Columbia and the Territories) to assist 
states in providing medical acute and long-tcnn care a~sis tance to people who meet certain 
eligibility criteria. Medicaid is the largest source of ftmding for medical and health-related 
services for people with limited income. 
The portion of the Medicaid program that is paid by the federal government, known as the 
Federal Medical Assistance Percentage (PMAP), is derennined annually for each s late by a 
formula that compares the state's average per capita income level with the national average. By 
law, the l~MAP cannot be lower than 50 percent or greater than 83 percent The wealthier states, 
as measured by per capita income, have a smaller share of the ir costs reimbmsed. The Federal 
government also shares in the state's expenditures for administration of the Medicaid program at 
generally 50 percent. Due to the entitlement nature of Medicaid, the amount of total federa l 
outlays for Medicaid has no statutory limit. 
Program Enrollment 
The Medicaid program, as the safety net for much of the nation's low-income uninsured 
population, has taken on an increasing responsibility for providing health coverage for this 
scgmcrll of the nation's population. For the live-year period from 1998 to 2003, tota l enrollment 
in the program incr~1scd by 30 percent. 
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Enrollment growth in the Medicaid program will play a large part in determining future 
spending. According to figures presented by the Centers for Medicare and Medicaid Services 
Office of the Actuary (CMS OACT) in the President's FY 2006 Budget, Medicaid enrollment is 
expected to increase from 54 miUion curollecs m 2003 to 65 tmllion 10 2015, a 2.1 perecm 
increase. The growth in enrollment will vary by digibi lity category, afTccting the share oftolal 
enrollees in ench of the four general categories or children. ndults with depcndcnl children, aged 
and disabled. 
Program Expenditures 
Consistent with IJ1e rnpid rise in enrollment, lvlcdicaid expcndi tmes increased nt a lbstcr rate than 
other iusurrtnce coverage types hctwccn 199!1 and 1003. Overall Medicaid expenditures 
increased by 62 percent !TomS 153 bill ion to $243 billion, wtth spending on crdults increasing by 
77 percent, tlw greatest increase among all enrol lment ca tcgones. Thc~c incn.:ascs compare to 
i ncrease~ of 5 1 percent for private insurance expenditures nnd 36 percent for Medicare over the 
~11111<: time period. 
Beginning in 2004 it is projected that the rate of tncrcasc in Medicatd spending will excce<l Lhc 
rate of incrc~sc in overall health care spend mg. Projections by 01\CT indicate that total health 
care spending will continue tO increase at over seven percent per year lor the ncxt l.cn years while 
J\kdicaid spending is expected to increase nt a ra1c or nearly eight percent per year. 
Additional estimates from OACT indicate tbat tot31 Medicaid spending wi ll increase from .$275 
billion in 2003 to $685 bi llion in 20 15, an ovcraln increase of almost 145 percent overthc 12· 
year period (7.9 percent per year). Federal spending will have inc reased from Sl 61 bill ion to 
$390 bill ion a11d state spending from $114 bill ion to $295 bill ion, increases of approximately 7.6 
percent per year and 8.2 percent per year rcspccti vely. 
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Recommendations for Savings 
The Medicaid Commission received over I 00 submiss•ons for constderation for the September l , 
2005 report. "!110 Medica id Commission charter directs the Commiss ion to " report to I he 
Secretary. for his consideration and submission to Congress. by September I, 2005, their 
rccommcndntirms on options to achieve $10 billion in scorablc Medicaid ~avings over 5 years 
while "t thc same lime make progress toward mcaningfid longer-term program changes to belle•· 
serve beneficiaries." Based on this requirement for scorablc savings, on ly options that have been 
previously scored by either the Congressional Budget Office (COO) or OACT, or that contained 
surficiMt detail upon submission to allow OACr to provide a score prior to the subsequent 
Commission meeting, ""d thut demonstrate savings in the 5-ycar peri od could be included as 
options tt) be present(..'(] to tl1e Comm1ssion for consic.Jcration. 
AI a pt1blic mccung convened August 17- 1 !!. 2005, the Commission dclihcra lcd and voted on 
proposed options for savings that were submincd according to !he guidel ine$ estab lished by the 
Commission allis Ju ly 27. 2005 meeting. Following prcscnt~1ti ons of all scored options . 
Chaim1an Govcmor Sundq Lnst and Vice-chair Govemor King prepared a "Chainnan 's Matk". 
This Mark was thei r suggestion of a package of o ptions which wou ld achieveS II bill ion in 
J\>lcdicaid savings over 5 years, and served as a starting point for the Commillec del iberations. 
The Mark consisted o f six Mthe options presented duri ng the fi rs t day of the meeting, and 
rcOcctcd the C hairs' recommendations to the Commission. 
All Commission members were provided au opportunity to discuss the individual opLions on 
the Mark, ask clarifying questions of Lhc subject mancr experts present, and move to amend 
the recommended package by suggesting omissions and substitutions of other options. Three 
motions were made for amendments. None of Lhc amendments had a suflicicntnumber of votes 
to pass, and the Chairmrul's Mark was not modified. The Commission Lheu voted tU1omimously 
to adopt the Chairman's Mark without amendment. 
The Commission recommends the following re forms: 
Prescription Drug Reimbursement Formula Reform 
Current Law 
Currently many states establ ish phrumaceutical prices based on the Average Vv'bolesale Price 
(AWl'). The A WP is me published suggested wholesaler price to retailers of a dn1g compiled by 
Lhird party compendia and is typically significanrly higher than the price acntally paid by 
purchasers of the drug (e.g., phamJacies. etc). lt is conunonly used by state Medicaid agencies 
as a basis for detemlining Estimated Acquisition Cost (EAC) for phanuacy reimbursement 
purposes. 
The EAC is the Medicaid agency's best estin1atc of the price generally and currently paid by 
providers for a drug marketed or sold by a particular manufacturer in the package size most 
rrequcntly purchased by l'roviders. It is used to detenmne the Medicaid's agency's phannacy 
provider payment and is typically set at a product 's A WP minus a percentage, but varies from 
slate to state. 
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Prop<lsal 
The Commission recommends allowing states to establ ish phammceu tical prices based on the 
Average Manuracturcr Price {AMP) rather than the published Average Whole~ale Price (A WP). 
Additionally, refonns should be implemented to ensure that manufacturers are appropriately 
reporting data. Such improvements should include rcfonns 10 ensure: I) clear guidance from 
CMS on nwnufacturcr price dctcnnination methods and the definition or AMP: 2) m<mufacturcr-
rcportcd prices arc easily auditablc so that systematic oversight of lhc price dctcrmi na ti()n can be 
done by HHS: 3) manufacturcr-rcp011cd pnccs and rebates are prov1ded to states monthly rather 
than the current quarterly reporting, and 4) new penalties arc implemented to discourage 
rn<lllul'aclun:rs li·om reporting inaccurate pricing in formation. 
Estimnl.:d Savings 
$4.3 Bi ll ion over 5 years (CMS Omcc of the Actuary)1 
Extension of the Medicaid Drug Rebate Program to Medicaid Managed 
Care 
Cuncnt Law 
Section 1927 oft he Social Security Act, effective January I, 1991 sets Jorth the requirements o r 
the Medicaid Drug Rebate Program. ln order for Federal Medicaid matching funds In be 
avni lablc to States for covered O\.i tpat i~nt drt1gs of a .nar,u facturcr. the manufacturer must enter 
into and have in effect a rebate agrccmcn1 with the Federal government. Wi thout an agreement 
in place, States cannot general ly receive Federal fi.U1dir1g for ou tpaticm dmgs dispensed to 
l'vledicaid rcc1pients. Rebate amounts received by states are considered a reduction in the amount 
expended by States for medical assistance for purposes of Federal matching funds under the 
Medicaid program. 
The basic rebate for brand nan1e drugs is the greater of 15. 1 percent of the Average Manufacturer 
Price (AMP) or AMP minus Best Price (BP). Best Price is the lowest price at which the 
manufacmrcr sells the covered outpatient drug t.o any purchaser, with certain statutory 
exceptions, in the United States in any pricing s l11Jcture, in the same quarter for which the A.tv!P 
is computed. 
The rebate for gener ic drugs is I I percent of AMP. 
Under current law Medicaid states cannot collect rebates from managed care organizations in the 
Medicaid Drug Rebate Program. 
1 Til esc cstunalcs for we reconlnlcodcd proposrus from the Office of U><· Actu:uy were based on available dewils 
and specifications. When spcclfic legislation is developed. these estimates may change. There is lhe possibilily that 
some or all of these proposals will imcract wilh one anolbcr and lhallhis could change lhe estimated savings o f~le 
tola l package. II prclimina•y es1imatc oflhc c1Tcc1 ofsu .. ;, interactions IS $200 millio11 m reduced savingS over 5 
yearS. 
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Proposal 
The Commission recommends providing Medicatd managed care health plans access lo the 
existing pharmaceut ical manufacturer rebate program currently available to other Medicaid 
heallh plrurs. States should have the option of collcc li ng these rebates directly or allowing l>lans 
lo ucccs~ them in exchange for lower capitauon payments. 
Estirnatcd Savings 
$2 Billion over 5 years (CMS Office of' the i\cwary) 2 
Change the Start Date of Penalty Period for Persons Transferring 
Assets for Medicaid Eligibility. 
Current l.aw 
StAl e~ dctermim: financinl el igibility lor l\llcdic!uid cc)vcrrtgc of nur~ ing home cnrc using a 
comhimtlion of $talc and fedi:r:tl statue and regulation. Personal income and assets must be 
below speciticd levels before eligibility can be csUJblishcd. Personal resources :u·c sorted into 
two cau:gories: thosc considered countable (tho:>e that must be spent down before cligibility 
critcrin is mel) and those considered non-countable (those that applicants cnn keep and still meet 
th.: eligibility criteria such as real .:state that tS the benclictary's primary res idence). Some assets 
held in tntst. Mnui ties and pr01mssory notes arc 31so no t count~d. If it is dctcm1ine{lthat the 
applicattt has hccss cOunlablc assets. these must spent before they can become e ligible. 
Personal incom.: is applied to the cost of care a ncr a pcrsonaJ needs allowance and a community 
spouse allowance is deducted. 
Federal law requires siatcs to review the assets of Medicaid appl icants for a period of thirty-~ i x 
month.s prior to application or sixty months if a trust is mvolved. This period is known as the 
" look back period." Financial eligibil ity scrccncrs look for transfers from personal assets made 
during the look back period that appear to have been made for the purpose of obtaining Medicaid 
eligibility. Transfers made before the look back period are not reviewed. 
Applicants are prohibited from trans ferring resources during the look back period for less than 
fair market value. Some transfers of resources are allowed. such as transfers between spouses. 
If a state eligibility scrcener ftnd.s a non-allowed transfer, current law (OBRA 1993) requ ires !Ire 
state to impose a " penalty period'. during which Medicaid wiJI not pay for long-tenn care. The 
leJJgth of the penalty period is calculated by clividing the amow1t transferred by the month ly 
private pay rate of nursing homes in the state. The penal ty period starts from the date of the 
transfer. Using the dat~ of the transfer as the start date provides an opportunity for applicants to 
preserve assets because some or aU of the penalty period may occur while the applicant was not 
paying privately for long teruJ care. 
' • Commissioner John Monahon suhmined • leuer 10 Chnimran Sundquist and Vice-Chairman !(jog on August 25. 
2005. requesting that with regard to !llis reconuncndauon. the Mcdtcaid mooagcd care organization rates should not 
be adversely impacted and that rate developmcm continue lobe subject lO the federnJ regulations requiring 
actuarially sound mtcs. The Jc.t1cr is to be included :15 supplementary infommtion to the rcpon ond can be found at 
h n '':; ;\v\vw. ems. hhs. g ov / f..'\calmt1<Jc uu 1s. asp. 
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Proposal 
Th.c Commission recommends moving tbc start date of penal ty period from the date vf the 
tran~fcr to the date of application for Medicaid or the nursing horne admission date, whichever is 
Iuter. 
Estimated Savings 
$ 1.4 Billion over 5 years (Congressional Budget Office) 3 
Increase the "Look-Back" Period from Three to Five Years 
Current Law 
fo' inancinl eligibi lity scrccncr:; look for trans fers from personal as~cts of Medicaid app licant8 
mack during a period of time pri or 10 applica tion (th is is referred to a.s the "look·back" period) 
that appear to have been made for the purpose or obtammg Mcdic:11d el igibi lity. Applic!LI1ts arc 
prohibited fi·om tmnsferring resources during the look back period for less I han fair market 
va lue. Currently, the '' look bn~k" period IS 36 months (3 years). 
Pro~ 
The Commission recommends increasmg the "look-back" period from 36 months to 5 years. 
Estim9tcd Savings 
Less than $ 100 mi llion over 5 years (CMS Office of the Acmary) 
Tiered Co-Payments for Prescription Drugs 
Current Law 
Fedeml stalute limits the amount of co-payments Lhai can be charged. In most cases, c~)­
payments of up to $3 can be imposed for prescription drugs, physician visits, and outpatient 
hospital visits. However, cenain categories ofbe.neficiarics, such as ch ildren tmder 18, pregnant 
women, and tbe institutionalized cannot be charged co-payments. Co-pays arc also prohibited 
for some services, including hosp ice care, emergency care. and fami ly planning and services. 
Proposal 
The Commission recommends allowing States th.: flex ibility to be able to increase co-payments 
on non-preferred drugs beyond nominal amounts when a preferred dntg is available, to 
enc.ourage beneficiaries to fill the least costly effective prescription for treatment. for 
beneficiaries at or below the federal poverty line, co-payments for preferred drugs should remain 
nominal. States should be given the ability to develop effective tiered co-pay stntctures to 
encourage cost-effective dmg utilizaiion where appropnate for all beneficiaries, regardless of 
income. All co-payments for tbe preferred drug list should become enforceable. States should be 
3 Commissioner Dougla.> Struyk submitted alener to Secretary Leavitt on August 29.2005, outlining his concern 
that cct1nin regulatory and/or legislative changes are ne-ed¢<1 to pn!•lcnt long.~ term care providers from bearing the 
fiJ\anciaJ implications of this rccommendntion. TI1c Je.Her is robe included as supplementary informalioo to the 
report an...._ cao be found al hllp;i/www.cms.hhs.go"ifacp/mcidemilsst-sp. 
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given broad aUibority to waive co-payments in cases of true hardship or where [Rilure to take a 
non-preferred drug might create serious adverse bealth effects. 
Estimated Savings 
$2 Bill ion over 5 years (CMS Office of the Act'uary} 
Reform of the Medicaid Managed Care Organization (MCO) Provider 
Tax Requirement 
Current Law 
Until 199 1. when Federal law restricted the usc of hea lth care prov ider rein ted tnxcs. States wore 
able to tax health care providers ll$ n way to rnisc their share of the Medicaid matching pnymcnt. 
These funds, used to dmwn down Fcdcrnl Mcdtcal(l dollurs were then returned to the provider, in 
effect, holding them harmless for the tax they originnlly paid This loophole in Feder<~ I law 
pcrrnill~d slates I() shift the cost of their Medicaid programs directl y to the Federal government. 
Aller 199 J, state taxes on health care providers were required to: 
• 8~ imposed on a pcnnissible class of health care services; 
• Be broad based or apply to all providers wi~'hin n class; 
• I3c unifom1, such that aJI provider; within a class must be taxed at the same rate ; and 
• Avoid hold harmless arrangements m which. collected la.xes nrc returned to the taxpayers 
directly or indirectly. 
• The Secretary shall approve broad based (and uniformity} waiver applications if the net 
impact oftl1e tax is generally redistributive and tha t the amount of the tax ts not directly 
correlated to Medicaid paymcms. The hold harmless requirements cannot be waived. 
The loophole 111 current law, whicb defmcs a.s a separate class of health care services the services 
of a Medicaid managed care organization, pennJ ts states to impose taxes solely on Medicaid. 
Managed care organizations are increasingly taking advantage of this loophole by reorganizing 
in order to protect the commercial lines of business from tax liability that is then targeted only on 
the Medicaid subsidiary of the managed care orgru1ization. 
lfthe reorganization of the managed care organizations with Medicaid contracts continues, all 
states could impose a tax only on the Medicaid n:vcnues of the managed care organizations, 
effectively shifting the entire burden of the rax to lhe Medicaid program. 
Proposal 
The Commission recommends changing !he law so that managed care organizations (MCOs) arc 
treated the same as other classes of bcalth care providers with respec t to provider tax unifom1ity 
requirements. Specifically, States would be rcqllired to tax all mrutaged care organizations. not 
j ustlhose with Medicaid contracts. in order to meet the unifonnity requ irements. States should 
be prevented from guamntceiog 1 hat tax revenues paid to stares by MCOs be returned. 
Estimated Savings 
$ .1.2 Bill ion ove· 5 years (Congressional Budget Office) 
LJ 
Future Work 
;\s directed by the chan.cr, the second mandate for the Meclic.tid Commi~sion is as follows: 
By December 31, 2006. the Commisston is tasked wi th making longer-term rccom.mendations on 
the future of the Medicaid program that ensure the long-temt sustainability of the program. 
The Commission shall develop proposals that address the following long-term issues: 
• Eligibi lity, benefi ts design und del ivery; 
• expanding the number of people covered wrth quality care whi le recognizing budget 
constrnints: 
• Long term care; 
• Quality of care, chotec, and bcncficmry sausfrtc tr on; 
• Program administrntion: ru1d 
• Other topics thut the Secrcurry may submit ~o the Commission. 
The Commission shall consider how to address these issues UJtdcr a butlgct scennrio thnt assumes 
federal and state spending under the current baseline: a scenario that assumes Congress will 
choose to lower the rate or growth in the program: and a scenario that may increase spending ror 
coverage. The Corn mission shall as~wnc that the basic matching relationship between the 
Fedcrnl government and the states will be conlrnucd. 
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Appendix 
Summaries of the Options for Ute September 1, 2005 Report 
Following are summaries oft he proposals being recommended by the Commission. Those narratives 
are cx.ccrpted from the fu ll summary document that contained narratives of a lithe scored options. and 
were provided to the Commissioners for their dcliberallons during the Augus t 17- ll!, 2005 meeting. 
The inlormation presented below for each option is taken directl y from tltc information providl:d by 
the author of the proposal. Each summary includes iang\lagc used by the proposal author lor the 
purpo~c of dc~cribi ng till: summary, key pointsllindings, and final thoughts lor each narmtivc. Any 
views prcscmcd in these sunmwrics do not necessarily rcOcct the vitws of the Commission and should 
not be construed as doing so bnsed on thc1r 111clusion in the Appendix section of this rcp(Jrt. 
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Asset Transfers 
Option 'i./6: Change the sh.nt date of the penalty period for persons transferring assets fo r Medicaid 
eligibi lity. 
Author: Ptesidertt's Budget FY 200() & National Governors Association 
Savings Ctncruted : $1.4 Bill ion over 5 years (2006-2010) 
Scored By: Congressional t:ltrdgct Office 
This option is among the eigh t ~avings proposals specific to the Medica id program included in the 
President's 2006 BudgcL presented to the publ ic Fcbnrary I I , 2005. 
URL: hll p://www. whitchousc.gov/omb/budgelffy2006/pdf/budgclfhhs.pdf 
Thi$ uption wns 1rlso submiuc:d by the Nation~ I Governors Association (NGA). NGA is the 
bipartisan orgunizalion of the nation's Governors. 
I 
BAC KGROUN_D (On~ to the complexity of thi s top ic, an overview of current l:lw regarding 
asset tn 111srcrs rs Jlrovtded.) 
Medicaid is the lorgcst payer for long tcnn care s.:n•iccs in the county. Medtcaid pay~ for long- lcmt 
care services for persons who arc poor and need long-term care, as well as for those who are nKtdc 
poor through paying pnvatcly the high cost of long-tcnn care serv ices. Determintng e ligibi lity for 
this later group presents n different cha llenge than for otltcr Medica id eligibi lity groups. 
States dclcr111 ine linanctal el igibility for Medieatd coverage of nurs ing home care using a 
combination of state and Jcdeml statue and regulation. Personal income and asscls must be below 
specified levels befo re eligibility can be c$tablished. Personal resources are sorted into two 
categories: those considered countable (those that must be spent down bcliJre eligibi lity criteria is 
met) and those considered non-countable (those tllat applic<mts can keep and stillmeet lhe eligibi lity 
criteria such as rea l estate). Some assets held in t.rusL annuities and promissory notes are also not 
counted . If it is detennined that the applicant has excess countable asse ts, tl1esc mu.s t spent before 
they can become e ligible. Personal income is appl ied to the cost of care after a personal needs 
allowance and a community spouse allowance is deducted. 
Federal law requires states to review the income and assets of Medicaid applicants for a period of 
thirty-six months prior to application or sixty months if a tmsr !S invo lved. This period is known as 
the ' ' look back period." Financial el igibility screcners look for trans fers from personal assets made 
durio.g the look back period thr.: appear to have been made for the purpose of obtaining :A.edicaid 
eligibility. Transfers made before the look back period are not reviewed. Some s tates and others 
maintain that thirty-six months is not a long en ough Lime to discourage transfers. 
Applican ts are prohibited from transferring reso\J.Il'ces during the look back period for less than fa ir 
market value. Some transfers of resources are allowed, such as transfers between ~p(luses. If a state 
eligibility screencr finds a non-allowed tmnsfer. current law (OBRA'93) requires the state to illlpose 
a "penalty period" duri ng which Medicaid w[ll not pay f'lr long-tetm care. The length of the penally 
peri(!d is calculated by divid ing the amoun t transferred by the mon thly private pay rate of nursing 
homes in the state. The penally period starts fromlbe date of the transfer. Using the date oflhc 
transfer as the start date provides an opportunity for appl icants to preserve assets because some or all 
of the penalty period may occur while the appilcaJl t was not paying privately for long term care. 
Some e lder law attomcys advise their clients on how to use the penalty penod t(l retain assets. 
A~~ct T ran.st'ers 
The following two proposals sugge~t ways t<J change the way Medicaid detem1ines on applicant's 
financial el igibi lity for nursmg home care. Both proposals alter aspects of the penalty period and one 
or thcrn goes fi.•rthcr to also change the length of the look back period. 
I SUMMARY 
The Administra tion proposes to move the st~ rt date of penalty period from the date of the transfer to 
the dale of app lication for Medicaid or the nursing home admiss ion date wl11chcvcr i~ later. 
Changing this date extends the time during which Medicaid :•pplicants who malic transfers arc 
linnncially rcspMsiblc for the cost of the11· c11 rc. Such a change dec reases Medicaid cxpcncliltlres and 
incrca~cs privarc payment. 
lt<£Y POII'ITS/FINDJNGS 
o Then; is concem Jmong states and others that many persons who anticipate needing nurs ing horne 
care arc trans!i.:rring their asset~ for less than f~ ir mark.:t va lue 111 order to reduce prival.<: payment 
fo r care. 
o Curn:nt law provides an incentive for such transfers because even if such a transfe r is found, the 
application of the penalty period a.llows applicants to rctam a s ignificant share of their assets that 
might havc: been otherwise available 10 pay for long-term care. 
o A cottage industry of elder Jaw anomcys, as well as "half-a-loaf calculator wcbsilcs". inlom1 
consumers about how to time such transfers to maximjzc rctajncd assets while still qual ifying for 
Medicaid. Not only docs tlt is practice cost Medicaid in the ncar term, it also runs counter to the 
Depm1ment's efforts to encourage consumers to take control of their Jong-tcnn care and plan 
ahead for tbe care they may uecd. It is difftcuh to make tl1e case for advance financial planning 
while such other arrangements are available. 
I fiNAL CONSIDERATiONS 
Many consumer advocates fear that changes to the transfer of assets policy wi ll impose hardship on 
persons needing long-tenn care. In cases in which a transfer i$ found and a penalty period is 
imposed U1cy suggest that applicants, unable 10 pay for services privately, wi ll be forced to go 
without care. Stares arc required to have hardship provis ions in place to assist those unable to make 
other arrangements; however, little research ex.ists on well such provisions operate. 
Commissioners Angus King, Julianne Beckert on behalf of f ami ly Voices. Joseph W. "Chip" 
Marshall, lil, and Douglas Struyk on behalf of the American Association of Homes and Services lor 
the Aging and the American Health Care Association, submitted proposals that endorsed reforms of 
the asset t.ransfer penalty and the look-back period, but did not provide sull'icicnt detail to score as 
separate proposals. They did not endorse this spe-cific proposal but arc generally in support of 
refom1ing this area of Medicaid. 
Commissioner Valerie David~on has requested that the following recommendation be considered 
during the discussion of this rcfonn option: 
Asset Transfers 
At a minimum. afl assets of A llAN individuals described in CMS's State Medicttid ;\!fanual. Section 
381 O.A. 7 should be exempt from Medicaid eligibifuy calculatWIIs and estate recovery provtsions. 
01\CT has estimated that amending the proposal lo include this recommenda tion wou ld result in 
approximately a I percent lo~s in the est imated savings overall. 
Swtc Mcdicnid Mtltlrml Sectilln 3810.-f. 7: 
,4merkou ludlans nne/ Aloskfl Naill'(',~. nre Fed,~ral go-.c•rmtwnt llfl.)' (I unlqtn: Int.'ff ~'/I(Jrl.'tib/1/ty jiJI· Alllel'icwr lmlltm 
(A I) Tribes mul Alu.<k!l Nath·~ (AN) Village.< oud their memlnrr.< S<'Ciimr /9/l(b)(J) ofthr• S<1clal Security 11<'1 glt•u., the 
Sl'l'r(•lm1' lltlllwri~v w t.J,,.tubli:riJ Slfmdnrd.\ (or lmrdshrp. This mdmles t!Xemptmru from c.ftnre retoven•j(Jr t't>r!alu assets 
mul 1'1.',\'(}lrrn•,\ 
·'· 1lmcric;u1 Jud!>UIS and AIA~ka :-lnt11·cs: lnt(lmc. Rcsou[lli.,10JL~rty Excmm from Mcdtc~jd !i~ll\\C Hc~ovcrv.­
r)tc fo llowing AI! AN incomo, r<'SOUtC<!>, nno propcny 31'C exempt from Medicllld CSIIItc recovery: 
l. Ccrt~un /\ liAN mcome and resource!' (~uch :lS antc,csts m nnd mcomc dcn .. ·ed from 'l'nb;tllaud '"'d othct· 
resources current ly held m Lrust .~aa1us nnd ;udgme-nr ftmds from the lndmn Clmms Commts~tOn :lnd the U.S. 
Clnii'Jts C'OUJ1) Lhnl nrc .:xcmpt from Mtd1cnid ~I!Hc recovery by other laws :md regulations: 
2. (>wncrsh'l' inlercst I ll uusl ol' uon-tn.ast propcny. m~lmhng real property 'tnd unprovcmcnls: 
a. Locnted on n re~crvatiou (rmy fcdemlly·rccogm>.co lndinn Trtbc's n::.crvation. Pueblo, or Colony, ulcludiug 
f()nncr ••escrvntions in Oklahon>:l, ,\lnskn Nnuvc regions cst~blished by Ab~k!t Native Clnints Settlemen t 
Ac• and Indian allotment~) nt ncar n rc-l';rrvruion as dc:.ag.nmed nnd nppro\•cU by the Burcuu of lndinn Art:\ irs 
of the U.S. Ueprtnmcnt of the lntcriur, or 
b. for :lit)' fcdcrnlly rccogniLcd Tnbe not dc.cribc:d in (a), ln<:3tcd within the n>Mt r«:cm bouud~rics ofn prior 
Fcdcrn l rcscrvmion. 
c. Protection of non-tnJSt property descnbcd m (a) and (b) IS I muted to circwnstancos when it passes ft·om 
nu lnduw (&~defined in seclion 4 of r.hc Indian Hcnllh Care Jmprovcmcul Act) lO one or more rd~tt ivcs 
(by blood, ndopuon, or marnage}, mcluding Indians not enrolled as member~ ofn Tribe and non-
lnd.ans, such as spouses and step-cluldrcn, that their culture wmLid ncvcnhclcss protect as family 
members; 10 a Tribe or Tnbal organtzauon: and/or to one or more Indians; 
3. Income l,;ft as a remainderman estate dcri,•cd from property protected in 2 above, t:bat was titl1er collected by 
nn Indian, or by • Tribe or Tribal organization and dmnbutcd to lndtan(s), as long as !he individual can clearly 
IJ'acc it a.s coming from the pr01ectcd property 
4. Ownership intcre:;1s lcfl as a remainder in an t."State in rems, leases, royaltiesJ or usage rights related to natural 
resources (includmg cxtr.>ction of naturnl resources or han•esring of timber, other planrs and plam products, 
animals, fish, and shellfish) resulting from the c.xercisc of fcdcrally-prorected rights. and Income either collected 
by an Indian. or by a Tribe or Tribal organization and distributed to lndian(s) derived from these sources ;~s long 
as th~ individual can clearly trace it a.< comiog from protected sources; and 
5. Ownership interests in or usage rights to items not covered by 1-4 abo\'e that have unique religio-us, spiritual, 
traditional, andior culnm•l significance or rights that support subsistence or a traditional life style according to 
applicable Tribal law or ctt"om. 
b. American Indians and Alaska Nauvc.< Income, Re.,ources and Prooertv Not Exempt from Medtcatd Estate Rccovcrv. 
- You may recover the following income, resources and property from the estates of American Indians and Alaska 
Nativ~s: 
I. Ownership imcrcsts in assets and property, both =I and personal. which are not described in7.a, ilcm.~ 1-5 
above. 
2. Any income ond assets left a!; a remainder in atl estate that do not dt..'Tivc from protected property or sources io 
7.a, items 1·5. 
OptiQn 7: Extend the asset tmnsfer look back period from three to 5 years. 
Author: National Govemors Association 
Savings Generated: Less tlmn $100 Mil lion over5 years (2006-201 0) 
Scored B\•: CMS Office of the Actuary 
Asset Transfers 
The Nnlional Governors Associalion (NGA) is tlhc bipartisan organi<.ation of lhe nation's Governors. 
The savmgs option presented below IS a summary interpretation based upon lhc NGA 's dratl working 
paper on Mcdicuiu reform , provided 10 lhc Medicaid Commi~sion in August 2005. The cs timnlion M 
the savings genera led is also based on the intcrprctallon of the opt10n presented. 
I SUMMARY 
Slalcs should have increased ubi li ly to prcvcnl inappropriate lmn~fcr of assets by seniors to qua li fy 
lor lv!cdica id. To thai end, the look-back pcnod shoulu be increased from lhrcc to five years. 
Accordingly, if ~t any time du ri ng the applicable: five year look-back period an npplicant. the 
applicnut's spouse, or a fiduciary tlr person nctmg for 1hc applicant, the nppl icnnL's spouS'c, or both , 
1ransfcrs or soqucs1ers resources or I he right 10 receive resources, income, or both. from 1my sotu·cc, 
and as a result of the transfer or sequestration the funds available to pay for medical ass istance arc 
diminished, the applicant shall be ineligible for medical assistance for U1c period of lime thnt woultl 
cause the tra11sfcrrcd or sequestered resources. income, or both, to be fu lly expended at the wcigbted 
average nursing facility rate Ill effect when 1bc transfer or sequestration occurred (either the monthly 
rmc or the da ily per diem multiplied by 30.42 and rounded to the nearest do llar). 
lf the tTansfer is between spouses llus rule does not apply 10 1he extent that the tTansfer does not cause 
the transferees' resources and rights to receive income, rcsomccs, or both, to exceed the maximum 
community spouse resource allowance in eftec1 at the time of the transtcr. Tills same exemption also 
applies to dependent disabled children. Furthermore, if a dependen t disabled child is living in their 
parent(s) home at a time such parent is applying for Medicaid, that child has the right to stay in the 
home. Ln the evcm of death of the chilcl the state then has the right to recover the asset of the home. 
I KEY POINTS/FINI)J.NGS 
c The CRS Report for Congress Medicaid and SCHTP: T~e President's FY2006 Budget Proposals, 
published Febmary 15, 2005 states that Medicaid law includes provisions establishing penalties 
for individuals who transfer assets for less than fair market value for the purpose of becoming 
Medicaid-e) igible. 
o Specifically, Medicaid law requires states to de lay Meuicaid eligibi lity for persons needing 
institutional coverage (including nmsing bomc care) and certain home and community-based 
services who transfer assets on or before a "look-back date. •· 
o For most assets, this dale is 36 months (thre<: years) prior to Medicaid application. 
I FINAL CONSIDERATIONS 
Com111issioner Jo~eph W. "Chip" Marshall. Il l, endorsed asset transfer refonns consistent with this 
NGA proposa l. 
Cost Sharing 
Option I 0: Providing states flexibility in dctinmg co-paym~nt requireiJleots for prescription 
drugs requirements. 
Aotllor: National Gavcmors Association 
Savings Generated: $2 Billion over 5 years (2006-2010) 
Scored By: CMS Office of the Actufli)' 
The National Govcrntlrs Association (NO A) ts the bipartisan organiz:llion or the nation ·s 
Govcrn()r.;_ The suving> option presented below is a summ~ry interpretation based upon the 
NGA 's draft working paper on Mcthcatd reforn1. provided to the Medicaid Commiss ion in 
August 2005. Th~; estimat ion of the savmgs gct1cratcd is also based on the 
interpretation of the option presented 
I SUMMARY 
StJlC$ should be gi \•cn the ability 10 develop effective tiered co-pay stn"tures to cncourngc cost-
cf'lcctivc dntg utilization where appropriate for a ll beneficiaries. rcgurd lcss of income. Although 
state~ may currently operate tiered co- pays. Medicaid's cu tTcnt cost shnring niles , with nn 
uncnforceabl ~: maximum co-pay of$3 per drug i.s not conducive to encouraging cost-effective 
util i·.wtion. States should be able to increase co-pays on non-pre ferred drugs beyond notninal 
amount~ when a preferred drug is available, to encourage beneficiaries to fil l the least costly 
effective prescription for treatment Such co-pays must be enforceable to be mcnningful. 
For beneficiaries at or below the fcdentl poverty level, co-payments for preferred drugs would 
remain nominal, although they would be enforceable. For this population, states would be able 
to increase these enforceable co-payments beyond nominal amounts tbr a non-preferred drug. 
States should be given broad authority to waive these co-pays in cases of true hardship or where 
failure to take a preferred drug might create serious adverse health effects. 
I KEY POINTS/FTNDlNGS 
o There are approximately 6.3 million Medicaid beneficiaries who are currently e ligible for or 
receiving benefits through both Medicare and Medicaid" Medica id will no longer be 
respor.>ible for providing prescription drug coverage to these b::neficiaries beginning January 
I , 2006. 4 
o On average 24 percem of all eligibles in Mcdlicaid pbannacy be.nefit management managed 
care utilize prescrip tion benefits.5 
'
1 Medicare Modernization Act, Pharmacy MMA Information, Medicare Help at the CoiUHcr: 
Medicare R.x Update June 10,2005. Available 011linc at: 
http://www.cms.hhs.gov/medicarerefomllpharmacy/updatc06l 005.asp. 
5 Pharmaceutical Care Network. April 2004. Phannacy Benchmark Study for Managed 
Medicaid Health Plm~5- / _•,ailablc onl ine at: 
http://www .pham\carcnctconllpdJ.Ibcnchmarks _medicaid_ 2004 .pdf. 
Cost Sharing 
I FlKAL CONSID.ERATlONS 
Commissioner Angus King submitted a broad proposal that endorsed applying enforceable co-
payments for prescription dmgs. but did not provide sufficient detail to score as a separa te 
proposal. He did not necessari ly endorse this spcc1fic proposal but IS generally in s upport of 
reforming this area or Medicaid. 
Prescription Drug Rclonn 
Option 16: Mcdicaidpres.cription drug reimbursemcnr fotmu.larefunn. 
Author : N;llionaJ Govemors Association 
Savings Gcnerat~d: $4.3l3illion ovcr 5 years (2006-20l0) 
Scored By: CMS Office of the Acittary 
The National Governors Association (NGA) is the bipartisan organt.cation of the nation's 
Governors. The savings option presented below is a summary interpretation based upon the 
NG/\ ·~ dral1 working paper on Medicaid refom1, provided to tJ1c Medicaid Commission in 
August 2(105. The estimation of the snvings generated is also based on the 
interpretatiOn of the option presented. 
I SUMMARY 
States negotiate prices on prcscnption drugs accordmg 10 the publtshed average wholesale price 
(/\ WP). Th.:ro.: is widespread acceptance that AWl' is inllatcd <lnd docs not reflect a va lid 
benchmark for pricing. A different reference price should be established and mad<: avai lable to 
the states tJwtmorc accurmcly rcnccts lite actua l pncc ror dmgs. The Average Manufac tutcr 
Price (AMP) shnuld be used for this purpose. 
I KEY PO INTS/FINDLNGS 
If AMI' replaces AWP in prici11g, rcfonns need to be made to ensure thatmanufact11rers arc 
appropriately reporting pricing data. Such improvements should mclude retonns to ensure: I) 
clear guidunce from CMS onmanufacrurcr price dctem1inauon methotl~ and the definition of 
AMP; 2) manufacturer-reported prices arc easi ly audi table so that systematic overs ight of the 
price detem1ination can be done by HHS; 3) nianufacmrcr-rcportcd prices and rebates should be 
provided to states month ly rather than the curreot quarterly reponing; and 4) new penalties are 
implemented to discourage manufacntrers from reporting inaccurate pricing infom1ation. 
I FINAL CONSIDERATIONS 
Recent reports by the Gener~~ Accounting Office (GAO) and the Office of Inspector Ceneral 
(OlG) concluded that improvements in manufacturer price detem1inatiou methods and reporting, 
and increased oversight by CMS are essential to e-nsu re that AJVlP is a reliable and accurate 
reference price for states if AMP is to be used for the pharmacy reimbursement formula. 
Prescription Drug Refom1 
Option 20/2.1: Extension of the Medicaid drugreblite progmm (o Medicaid managed care. 
A uthor: National Governors Association & the Association ofComruw1ity Affiliated Plan~ 
Savings C~llerflti'd: $2 Billion over 5 yearS (2006-2010) 
Scored Uy: CMS Office of the ActUS()' 
The National Governors Association (NGA) is the bipartisan organization of the nation's 
Governors. The savings option presented below as a summary interpretata on based upon the 
NGA 's drafl working pap<:r on Medicaid reforn1. provided io the Mcdie;aid Commission in 
August 2005. The csainmtion of the savings generated is also based on the 
interpretation of the opuon presented. 
The Associatiou for Commumty A ffil iatccJ Plan~ (ACt\ P) is a na tional trade association 
rcprcscming "snfcty net health plans" thot :arc Mcdica1d-focused and arc non-profit or owned by 
non-profit entities like publ ic hospita ls or communi ty health centers. As of July 2005, ACAP 
represents 19 plans serving 2.1 million Mcdacatd bcnclicaarics m 12 stales. ACi\ r plans serve 
one of every six Mcuic:ticl managed care enrollees. 
I SUMMARY 
i\s more and nJot·c states utilaze managed care to help administer thcar program, managed care 
co111panics should be <1ble to directly access rebates for prcscnption drugs purchased for th.;ir 
Medicaid population. States should have the opt ion of collecting these rebates directly or 
allowing plans to access them in exchange for lower capi tation payments. 
! KEY J>OJNT S/FlNDINGS 
o A Center for Health Care Strategies (CHCSj repon concluded that MCOs arc ab le to reduce 
their average per member per month (PMPM) drug costs for families in Medicaid managed 
care to $17.36 compared to $20.46 in the state FFS programs. 
o A Lewin report concluded that Ariz-ona 's managed care program was able to achieve the 
lowest pharmacy costs in the nation at the time of the study, 38 percent below the national 
Jvledicaid average. 
o Suppon for this refonn proposal from mcludes the following organizations: National 
Association of State Medicaid Dir~ctors, Medicaid HeaHh Plans of America. 
I FINAL COl'ISJDERATJONS 
Because managed care penetration varies widely by state, the Fiscal impact of a refonu of this 
nature would vaty considerably across states. Therefore, while it may achieve overal l savings 
for the Federal govenunent , not all states would experience measurable savings. 
Provider Taxes 
Option 30: Rcforlll of Medicaid Managed Care Organization piOVidcr tax requirements. 
Author: Prcsidcnfs Budget FY 2006 
Savings Generated: $1.2 Billion O\Yc;r 5 years (2006-20 I 0) 
Scored By: tongressionall3udgct Office 
This option i$ among the eight savings proposa ls spceilic to the Mc<lica iJ program included in 
the President 's 2006 Budget. presen ted to the public Fcbnmy I I, 2005. 
URL: http://www.whitchousc.gov/omblbudgct!fy2006/pdti'budgctlhhs.pdf 
I SUMMARY 
The 2006 Budget proposes to requ ire that ma naged care organ i za tion~ (MCOs) be treated tit.: 
same a~ other cl u~scs o f hea lth care providers wi th rc~pcct to un ifbnnity requi rements. Und.:r 
this proposHI, ~tatcs would be prevented from guaraJHccing that t:•x revenues patd to stntcs by 
MCOs would be returned. 
I KEY I'OINTS/FlNOlNCS 
o Provider taxes nrc n linancing mcehnmsm sta tes have used to generate state funds needed to 
obtain fcdcra l Medica id matclting payments. 
o Dul'ing the mid 1980s, states began usiJlg pro,•idcr taxes as a mechanism to leverage 
addi tional federal f11nds and cost sluft Mcdicatd expenses 10 the Federal government. After 
the taxes were matched with federal funds and paid to the providers. the providers did not 
keep the payments. 1 nstead. the providers rc turned most of the fed era I monies to the states, 
where the funds could be used for other purposes . 
o In 1991 , the Congress passed legislation to l imit states' use o f provider mxes. 
o CRS reports that w1der current law. Medicaid MCOs are treated differently than other 
providers regarding provider taxes. 
o As a result, stales currently may tax Medicaid MCOs and provide a guarantee that the tax 
revenues w ill be rernmcd to the MCOs. States may rece ive the full federal match for the tax 
funds that are rernmed. 
I FINAL CONSIDE RATIONS 
These proposals arc intended to strengthen requirements and ensure the fiscal integrity ortl1e 
Medicaid program. 
CRS states that this proposal w ill pertajn 10 both Medicaid and non-Medicaid MCOs. 
Commissioners Grace-Marie Turner and Robert Helms endorsed payment refomts consisteot 
w.ith this Administrat ion proposa l. 
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Stntq Spol'\i9red 9U$In~so 
1 11111 wrili•JS.IO •·equc.st incht.ion in 1he Commission's report an important clnriticntion regarding tl:te 
r~comnwndation to ~xp:mcl access to the Medic~id Presc.riprion Drvg lt.:bah> Progrom ro Medicaid Manag~d 
Care Q, gani:tJJ\lons (MCOs) [ad.~>pt ion of Option 112 I, •· Extell$lou or t·hc VJ~uic;1ld Drug Rcbllhl progrnm 
to Medicaid Mnnngcd Csrc"l· ln adopting th1s proposnl, !appreciate cbe Commission' s roeognition of 
MCO success with drug benefit mnnagernenl tools thnt provide climcally sound nnd cosl eflllctive drug 
benefits to members. As I mentioned at the Commission mectins last week, however, it i~ crilic;tl to ioclude 
an elllphnsis on acmarially sound Medicaid managed ~re t11lcs for prescription drug wd m~dicul benefits. 
The successful role of MCOs in managing Medicaid drug benefitS requires thnr, MCO rate-settlrig be 
consistent, rclia~le l!nd aewarial ly sound. Federal La wand CMS (>Uidclhtes require states to actuarinlly 
certify Medicaid MCO rates. but~ome states apply an arbitrary fuctor outside the nctuario I rate-sertinjl' process 
to meet annual budget requirements. Uncertainty nnd now payment rates lead to market disruption and fewer 
cho.ices for enrollee$. Establishing rates that are not actuar.iaJly derived undermine the demonstrated aoility of 
nlUJJaged Olll:e to improve access to quality care for enrollees, and lower program costs for states. 
For these reasons, states should not view expanding the{V!edicaid Drug Rebate Program as another potential 
".factor" to be used to arbitrarily 1\.-duce.MCO fees. TCD assist states in setrh1g MCO rates, tl1e American 
Academy of Actuaries (AAA) recently developed gujd!elint:s fur states specific to Medicaid MCOs. 1 
recommend that the Commission rcflecnhese guidelines in its report by slAting that. wjth resP.ect to sayings 
identified ill option #21., "Extension ofiheMedicaid Drug Reban. Pmgram to M<:dicaid Managed Care", the 
Medicaid Commission supports this option witb the understanding that Medicaid MCO rates should not be 
adversely impacted and 1hat rate development eontinue to be subject to the federal regulations requiring 
actuar!ally sound rates. 
· I am honored to participate in lheMedi.caid Commission. l look forward to ilie work ahead of us and 
appreciate the leadership you are providing. 
Sincerely, 
)tri-P.~ 
!Ctm r>. Mouabau 
~~ Christian 
@ ® Health Care 
Center 
J\ugu$t 29. 2005 
11oe l ion. Michael 0. l..enviu 
Secretary. U.S. Deportment of Ncahh nnd Human Scrvocc' 
2(1() Independent A''~IIUC, S,W 
Wnsllingl\111, I)C 202H I 
lh~: Mcdit.:akl (\Jmmis:sion rcnHrun~ndntinn on As,\Ct Trnnc,lcr\ 
ncar St."trelary Lc.nvitt: 
Fin:1. I wan1 co thunk you •tgtun fnr nppotnung me to the Mcdu:-~ud Commission. I ;u1l hmwrcd lO h;we been .. cleclt.:d ns 11 
Conu'lus:-.mucr ~mel I feel c.ncoumgcd 1hmllu:. group, ... encrg11,ccl and C~lpable of lm.:klinN the dirticull and complicated challenges 
USSllCtllrCI.I Wtlh pror>O~tng refonns of the McdicuH.l ~y~rem. At the suggestion or C.:hairman Sund(JUjst dul'lng 0111' I"CCCnl 
AuAnsl 11! mc·cling. I wnnt to pro•·fdc some fmporro_ntt infom1nlion 9nd n rclntcd request. This is done to provide you with 
n cousens:us of the. Commls.{)ion's discussions pertn1n:ing to un imp<)rtAnt aspect or the ils..">ct transfer matter contained in 
I he C()Jilffi isSiOn'S I'CC<~nf fCCOITIOI(:nduliOns tO yOU. 
Since the long·tcrm care prx>fession hns long :.dvocatcd for mnny reforrn< wit/lin the Mcdocuod progrnm, I cspccinlly HpprccratecJ 
1.he djscussion in 1.he Colllrnissiou ·s mcecing re~~tn.Jing ll.SSeC mmsfer issues. My colleagues .and I have long belicvctl that there is 
little incentive for Americans to plan for their lnng-tcrm c<~re '"'hr:n. with lhc advice of elder law auorncys. they can srr·ucturc 
assets in n WU)• us 10 become eligible for Medic:tid wben the)' would otherwise have been using Lht:ir own resout'Ccs. The 
Aml!rican Health Cnrc: AssociafH)ll nnd the .American A . ..;sociation of Home.!~ and Service' for the t\ging. tm behalf uf my 
orgaoi1.aLion nnd others, haw ndvocatetl for chBnge '" tllis area. It was very encouraging to see th~ President's support for th is 
mauer hy ~ddressing it in hls reecnl budge-t proposal. 
'lllt'. long~tcnn care profcs~ion i~ in agreement with the underlying policy objccti\.'C of strenglhening our nation's lt1Wti on :~sset 
tnonsfers in order to discourage t\mericans from practices that have abused tbe Medicaid system. We are concerned, however, 
with lhe financial ha rd.lbip that long·lenn care pro•' iders may bear,~,, a result or ch•mging the d:ole when the penalty is 
incurred. As l discussed wirh Dennis Smith during Ills testimony before the Medtcaid Commission. if the penalty dale is 
changed 10 ohe date on which an ind1vidual is o01erwise seeking eligibility for medical ussrstance, long·tcnn care providers may 
not receive payment for care being pro\·ided 10 indi"iduals who are already residents m a facmty at the time of application. ·n1is 
may have been an unintended consequence l>ut os certmnly a real and very damaging potential result for providers. Nursing 
facility providers mav bt forced to care for a significant number of beneficiaries without oayment. fn short. the tQ1al cost of care 
will be shifted from the federal and state government to providers - and oot back to the individuals who have transferred their 
assets (or re<:eived these assets) so as to esc-ape respons ibility for payment. 
Nursing facilities will have no option. due to a combination of law and reality, other than to absorb the cn$1 {lf care for these 
residents. The current provision< of Federal law under OBRA 1987 prohibit nursing facili ties from requiring a third·party 
guarantee of payment upon admission~ thus, there: is no one with rtsources to tum to for payment. \Vhilc discharging re~idents 
under such circumsonnces may be pcmoined by law. it ma)' take as many as s ix months or more to transfer or discharge a resideno 
for non·payment. 13ven when a facil ity can legally transfer or discharge. there is often no place to send the resident. Fam ilies will 
not take tlocm because >hey require norsmg facility care and no other f<tcility or hospital will accept them as they hlli'C an 
inability to pay for ~1eir care. 
During the Medicaid Commission's Augu» 17th meeting. CMS staff in anendnnce brought to the Commission's and Dennis 
Smilh's attencionLhat a recipient cou ld f11c a "hardsh1p c..'cmpljon ... Titc Conuni~iun's discussion~ that en~m:d aboul this mntler 
mndc it dear 1Juat lhe c(mscn~us of the group wn.s 1ha1 prov1ders should not Oe harmed by this chnnge in policy. Furthermore. the 
"hardship exemption'' inl'om1ation that "'as pruvoded by CMS staff was understood to be nn ctl'ectivc prcvcntivn 10 any such 
JOI S1comac Avenue • Wyckoff. ~J 07481 • ( ~01 ) 8.J8·poo • www.chccn i.org 
potential hann. Subsequem 10 the meeung. I :mempred ro gather more 111formauon on llus practice i'rom CMS staff. As I have 
now learned. Chc fttciiHy muM fi~t gwc a noucc of discharge for non paymr:nl to the resident. Th\!n, chc rcsidcnl couhJ fife fo1· a 
h:lfd,hip exemption. TI•is IS a roc1pienr uppcnl. not r• fac•hty appeal. nod rnost likely the fncihty could not compel the resident to 
liJc. ,\JI)' of lhc.·sc scenarios plucc!. t11c focility jn u no .. v. i11 suuation 
lkc.o!UI!lcndmious 
While I Hgrce wnh lhc undcrfy1ng, pohcy positiOn. It 1s cn ucal 10 an1CI1or:nc HS ncgau·.-e impact on pi'OVIdcn•. Opl10ns Include: 
:t) Pc11u11 J:u:ilhic\- 10 ask for m(lre finnnci:sl infnrmAUCHI than i~ currently ltlluwcd <.luring the l\pplic;:uiou p!'OC~~::: 11tu1 "<1uld 
lu- Jr di:\1.'0\'CI if lhC-rC' WOt. lln unremli-t:~ib)c tr:ln.:..fer Wllhlll I he! luok-h.td, pcrivtJ that C~lUhJ I'C~UII iu the illlpOSilinll of a 
pcnuh;. Under curTcm rcgulntlCin .... (acabiiC~ nrc !-CVcrely limttcd rt\ to the type or infunn;tlion nnd nt'l~unuu;c~ lh:tl Clill he 
ohu1i n~d HI thul time rtuu would miltgntc unfair n" k tn pmvu.lcr,, 
b) Pi;HUil faci lil it:!to t() I'C:(JU!n: ll thud~pJtny gu:trnnt\!C ~· payment ror the: pertod llri"'IIIS rrom th~: hnpm.iciou uf a l l'llllSI'cr 
fX:.rHIII y, 
c) Upon rcqut:sts of chc provider, gnuu lhc proYidcr a hn.n.Jsh1p wnwer of inel•~:ttbt l ity in casc:oi wh<.:r<.: indlvidu~• ls me :t lrc~1dy 
rc.,idenl!\ in h:.ng~tcrm c~are rru:~ilit1t..., n1 the ttmc of npphcAti\)O for mcdtcaiH.s~•stnncc. 
d) Pcrrni t fadlilies to chargl! Ltus type of unt:ompen::uuctl care tn b;1d debt:. lf the facility obtained n SIJHcmcm pdor w 
tuhu lsSHlll chu1 1hc. rcsrdcnt had not made a tr.UJ~fcr 1h~11 wou ld re~uh 111 a penally ~md it IS l::ttcl' dlsc(wercd lh:lt the 
su:Hcmenl wns inoccurrnc nod the fnclluy hns provided cure. 
c) 1Jenn11 fuciHties to deny :tdnllsswn u the reSident dasctoscs o t.rnnsfcr that could be deemed tmproper by the SUitt 1\'ledicnid 
Ehg•b•lity Worker. 
i) Pcnnit facilities to dl:ny admiSSIOn 1f ndequtue finnncial inforrmuion is not twai lable o r wiH not be pmvldcd hy the 
f)ro~pectivc re.~ident 
g) Tighten up the umc rrame for cJetermtning medical assisrnnce eligibility tuld enfor..:c thnl time frame with counties w 
t·ninimiz.e the fin:mcial exposure.~ to nursing racilities. This panicular rccummcnd-ut ion is only effective i f done. iu 
conjttnction wi1h one or more of the other recoanmendntiotas contained h~rcin. 
As l hnvc indicnted. my org~mi.za1ion and ot.bers , .. Hhin the ltmg h:ml care professton Sht\.re a strong eonvicciun that improp~r 
lrl'tn~fcrs. or funtl\ I() tl\•Oid payment ft>r long· term c.are is inappropri:ne and dam<lging to the Medicaid pl'Ogram. 1-fowcvel', 
shif1ing the financial burden of the care omo ~~~provider doe. uot achieve one purpose of the Stlcial Sccu1ity AcL, which is for 
d1e SUite and the federal go\'emmcnt through f«krnl financial participation IQ pay for care for carious categories of individuals 
who legilimmely cannot help themselves. In addilion. such shlf1ing puis into comple1e jeopardy the pri nciples of both Medicaid 
law nnd Section I I 15(a) caUing for Lhc preservation and eohanccmcm of beneficiary access 10 quality services. 
The long· term care profession agrees thac 1-tedicaid was never mteoded to be th1s nauon·s prilllary system for fllnding long-lerm 
t·.are and the indu.o,;try is in the forefront o f effons 10 encourage individuals to plan responsibly for. rheir own long renn care needs 
in advance. Our goal is enacrmem of nanonaJ policy tbal. over nme. replaces the current Medjcajd long Lerm care linanc·ing 
system with a national publlc/pri"ate. insurance·ba.scd (>rogram !hat provides financial suppon for individuals and their families 
to rake responsibility for financing their own long tenn <:are plannulJl needs: that will ensure access 10 quality scrviccs/~uppons 
at all points along ihe long term care spectrum for all individuals: and will provide financing stabilily in the marketplace and 
linancial recognition for family c~reg.ivers. 
Again. I greatly appreciate rhe opponunily 10 express my position on this issue. Because I feel so strongly abou1 it and because it 
generated considerable discussion in !he Commi.l.'>ion mteting I ask that my vicwpoinl be included in some fom> in !he repon. 
n tis could be accomplished as my lener serving as an addendum or as a note in the report. 
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Prcfacl' 
On June I S, 2005. NGA released a prelim mary policy paper th~t outl tned rccommcndauons for 
Mcdicnid Reform. This paper has n narrower fOC\tS 111 tha t it includes only those pu lic ic~ that 
could hecomc part of the rc\cnuc and spcnd111~ tcconciliatHln bills tlml will be deb:tlcd in 
September as pan of the 200(, federal budget. I he paper docs providt: more detail on the 
Govcmors' rccomrncndccl propos.tls for the spcndm~ rcconcthauon btll, but is conststcnt with 
th.: pohc} recommendations tn the June 15. 20()5 paper. 
Tit.: •·cconHnct1dat ions included 111 tlus paper "ere adopted by the (JUvcrnors because th.:y arc 
good puhlic pnlicy not tn sati st) uny spending n:duuion IJrgct. It ·~also true lhm Medicaid will 
con tinue to grow in the ht~;:h stn)! tc dtgll rtttc c\ell tf these poltctes :ue enacted. i\lletnativc ly. 
li·om a statt: budget pcrspccllve \1cdtcaid ts st tll unsustamablc. It tS th.:n:forc cnllcal that these 
rccomm.:udataons be con'ldcrcd '11 the bcgmmng. nut the end. of the refonn prucess. For 
Vlcdicmtl In he sustamable 111 the lung-run. broader progrum and health c~rc ref(mus must he 
consitkrcd. 
The CJovctnors apprcctntc the f,tct that the Mcdtcattl l'ommiss•on has come to many of lhc sante 
policy conclusions that arc recommended in tlu;, paper and they look 1\mvard to wnrking with 
them over the next 16 months as they focus on the long-run restntctunng of Medicaid 
I. )'rescription Drugs 
lnneascd ln111spnrcncy. Reforms are needed to bring greater transparency to pharmaceutical 
pricing methods for Medacaid. Currently, many states negotiate prices on prescription drugs 
according to the published average wholesale price (A \VP). There is wadespread acceptance tl1:u 
AWP is mflated and docs not reflect a ' 'alid benchmark for pricmg. A dtfferent reference price 
should be established and m:tde available to the states that more accurately reflects the actual 
price for drugs. 
The Average Manufacturer Price (AMP) shoulc.l be used for this purpose; however, refo1111s need 
to be made before AMP can be used as the ne\\ benchmark for tlrug pricing in Medicaid. 
Refom1s should include: I ) C ;\IS issuing clear guidance on manufacturer priced etcm1ination 
methods and the definition of AMP: 2) manufacturer-reported prices should be easily auditable 
so that systematic oversight of the price determination can be done by HHS; 3) manufacturer-
reported prices and rebates should be provided 10 states monthly rather than the current quarterly 
reporting; and 4) new penalties should be implemented to discourage manufacturers from 
reporting inaccurate pricing infom1ation.' The AMP should be used to establish a federal ceiling 
for phamJaccuticaJ reimbursement. States would sull retain the ability to negotiate lower prices. 
1 Recent 1 eport< by 1 he G cncral Accountmg 0 fficc (GAO) and the 0 ffice or t.upcctot General ( OIG) tdcutilied 
problem< with AMP, par!Jcutarty m nmnufacturcr pnce detem1ination methods UJld rep<>rting, and oversight by 
Cf!.·tS hn('lrovcrncnlS m lbl·se arcn~ a1c cs~cuuaJ to ens-urt that AM P as a rchable o.nd accurate rciCrcncc pdcc for 
stntes. 
Option for· Closed Formulary. States should have the option of adopting closed formu laries, 
j ust like the ICdcral govemmcm docs in the VA system and with the new Medic~re POPs. 
Adoption of a closed fonn ulary would mean Lhat the state would not be guaranteed a rebate or 
the "best price"; however. some swtes. with enough negotiating powe r and leverage . could 
negotiate lower overall drug prices than mthc current system. even with s upplementa l rebates. 2 
Ois~1cn sio~ Fees. Wnh the Introduction of a new price methodology (AMP). states should have 
fl cxihility to dctcm1inc appropriate dispensing fees for drugs. Dispensing fees slwuld not be 
linked to the price of drugs. us was pr<>posed by the President. nor should they be capped. 
Flexibil ity to dl:i crminc dispensing fees is important to ensure that pharm!lcics are ~lppropriately 
compcnsawd and thm r hannacists arc encouraged to disr ense the most cost-effecti ve drugs for 
henc liciancs. 
lnt'r·c:•sccl Minimum Rcha tes for Brand i'inme Drugs. rhc minimum rebates that states col lect 
on brand name drugs should be mcrcasctl to 20 percent (from 15.1 percent) to ensure lower total 
costs that would not solely impact pharmacists . Medicaid's "Best Price" provision $houkl not be 
climimucd in cxchan~;c for this. 
" Anthol'izccl Generics." For those states that conti nue to rely 011the Medicaid dn1g rcbme nJl(l 
"best price" provisions, reforms should be made to ensure that :ll) drugs be me ludcd in these 
calcu lations. "Au thorized generics'' should be inc luded in calculations of best price for the brand 
11M1C drug. I n &ddition. art "au1h0t1.r.ed gcnct•C" should qualify a particular dmg for l1aving a 
CMS set FUL. Currently, if at least three vers10ns o f the drug are rated as therapeutically 
equivalent by the FDA and the dn1g has at least three suppliers listed in cu!Tent editions of 
national compendia, an FUL should be set by CMS. 
Medicaid Managed Care. As more a nd m ore st ates util ize m an aged care l o help administer 
their program, managed care companies should be able to direclly access rebates for prescription 
dmgs purchased for their Medicaid population. States should have U1e option of collecting these 
rebates directly or allo"''tJJg plans to access tbem in exchange for lower capitation payments. 
Purchasing Pools. States should be given greater ability both within their state and between 
states in establishing purchasing pools. For those states that choose to forgo the "best price" and 
rebate in order to close their fommlary for the Medicaid program, they should be automatically 
able to combine their Medicaid population in with other state populations (e.g. stale employees) 
in order to negotiate greater savings. Amend OBRA '90 to require drug companies to give 
Medicaid level prices to state funded drug programs, including Medicaid managed care plans, 
SP APs, stand-alone SClUP programs, state employees, prison programs, and oU1er programs 
such as drug discount progranJS for low income residents of a state. 
2 No Olher emily in the health cart system is required by lllw 10 =inmin an open formulary. Medicaid taw (OBRi\ 
90) was wriucn so lhal ibis o pcn-cnde<i rc<juin:mcnt was to be balonced by gunranteed minimum reba1es from 
manut:1c1urcrs. Many Sl atc.s feel! hal l his l radc-ofT d oe$ not allow 1 hem 1 he rtexib ility 10 maiUige their programs 
effeclivcly or lbC abihly to truly negotiate deep cnoug b discounts. Currcnlly, sillies do nol have lhe oplion o f 
withdrawing fi·om 1he Dl'll{t Rebate Program wilhout sacnficiug federal fimlJlcial partic rpall<m lor prescription 
drugs. 
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Federal Upper Limit. To ensure that states do not pay too much for prescription drugs. a new 
federal reimbursement ceiling for payment for all drug products s hould be est~blishcd based on 
the AMP. In addition. the current practice of app lying a Federal Upper Limit (FU L) to c lasses or 
drugs with ll1ree therapeutically equiva len t products should he ma intained; however, the cun·ent 
FUL in this insttmcc is hascd on 150 percent of the A WP of the least costly therapeu tica ll y 
equivalent product, and should be revised to reflect 150 percent o i' the A:VlP oi' the least costl y 
therapeutica ll y equ ivalent product. -' 
Tic•·cd Copny for Presc ription Drugs. (Se'' Otrs .w:ct1011 1111der r·nst-s/l(tri11g.) 
Allow Mail Onler for l\lainten:m cc Drugs. Swtcs should be given the optton to req uire 
Mcdic~ id recipients to use mail order pham1acics to obt~ in their ma intenance drugs. Under such 
m1 option, the Medicaid statute would need to be changed tt1 allow "freedom of chotec" to bt.: 
wnivc-:~blc in this case at a states request. 
II . Long Term Care 
Asset Transfer. Stat"s should have mcrcascd ability to preven t inappropriate transfer of assets 
by seniors to qualify for Mcdtcai<l. To that end, I ) the look-back period should be increased from 
3 Lll 5 years; 2) penalty periods should begin at the time of applicaLiOil ; ru1d 3) the sheltering of 
excess resources in annuities. trusts or promissory notes must be prevented. 
Accordingly, if at any time dming t11e appl icable fi ve year look-back period an appl icant, the 
applicant's spouse, or a fiduciary or person acting for the applicant, the applicant's spouse, or 
both, transfers or sequesters resources or the right to receive resources, income, or both, from 
any source, and as a result of the transfer or sequestration the funds avai lable to pay for medical 
assistat1ce are diminished, the applicant shall be inelig ible for medical ass istance for the period 
of time that would cause the transferred or sequestered resources, income, or both, to be fully 
expended~~ the weighted average nursing faci lity rate in efTect when the transfer or sequeslrarion 
occurred (either the monthly rate or the dai ly per diem multiplied by 30.42 and rounded to the 
nearest dollar). The disqual ification period witn begin w ith the date of application for Medicaid 
long tem1 care services or if the ind ividua l is a recipient of Medicaid long tcnn care services at 
the time of the transfer, the disqualification period shall begin with the month following the 
month oflhe transfer. 
'Currently CMS sets FUI. for dmgs with geuertc equJValcnts, when there arc three therapeutically equivalent dmg 
products. The FUL is set at t50 percent of the published A WP price for lhe least costly therapeutically equJValcnt 
product. A recent OJG report foUJJd that Mcdicotd could sa''c htmdrcds of milltons of dollars per year by bastUg 
FUL amounts on reported AMPs. Accorrung to the report, if Mcdtcatd based FUL amounts on 150 percent of the 
lowest reported AJVlP rather than 150 percent of the lowest pubhshcd pncc (A WP).. the program may have saved up 
to $300 m.ilhon tn JUSt one quarter of 2004: illl estimated $650 m1llion per year of savings. Previous reports by the 
OIG in 2004 fouud that CMS does not effectively add quahfied drugs to the FUL list (e.g. O!G found that 90 drug 
products were not tllcluded on tile FUL list m 2001 tbat met lhe cutcna and had they been rhcy could have saved 
S t 23 mtllion m 2(101 ). CMS should ensure that a FULts set for quahfymg drugs m a timely manner. 
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I r the Lnmsfer is between spouses this rule does not apply to the extent that the transfer does not 
cause the transferees' resources and rights to receive income. resources, or both, to exceed the 
max imum community spoliSe resource allowance in effect at the time of the transfer. This same 
exemption also applies to dependent disabled children. Furthermore. if a dependent disabled 
c.hild is living in thc1r parent(s} home at a time such parent is applying for Medicaid, that child 
lws the right to stay in the home. In the event of d~ath of the dependent disab led child or the 
spouse, the state then has the nght to recover the asset of the home. 
ln tlte c~sc of Community Care Retirement and "Ltfe C~rc" Facihties (CCRCs). entrance 
d<:posi ts should he considered an av~ilab lc resource for purposes or dct~:rmining Medicaid 
l:ligihility, 11s CMS guidance currently dictates. 
Rcvcr·sc M<H·tg!lgcs. Ctment Jaw precludes the stale to include certain ass~:ts as "countable" i11 
detennining Medicaid ~: l i~ibil i ty, including homes. J'his leads to the current "pay ami chase" in 
estate recov~ry whcm stnlcs Hrc lcn to recover funds after hcncfictarics d1c. Reforms should h<: 
made to uvoid trying to recover funds after the rnct and instead lmvc individu:tls be n.:spOttsihlc 
up front for their health care costs. 
Homc ..:quity should be considcr~d a countable asset in order to requi re mdividuals to usc home 
cqui1y to off-set long-tenn and other medtca l expense~ that would otherwise be paid by 
Medicaid. Reverse motigage loans arc ;tvailnblc to allow seniors (age 62 or older} to convert 
home c<1uity into cash. To faci litate the use of reverse mortgages, however, reforms should be 
made to relieve seniors of the upfront costs of applying for such loans. For those seniors tltal arc 
applying for Medicaid, reforms shcmld be made to allow such costs be assumed into the annual 
payout or !he mortgage. 
Protections for seniors and the1r families should be put in place to allow a person who obraincd a 
reverse mortgage to afford Jong-tenn care and medical expenses to shelter a certain portion of 
their home equity. The anlotmt that would be sheltered would be IOpcrcent of the market value 
of the home or $50.000 (whichever is lower). States that can demonstrate that their current estate 
recovery programs are operating effectively, they should be able to opt-out ofth.is provision. 
Long-Term Care Insurance Par tnersh ip. To help the aging population plan for future long-
tenn care needs all stales should be allowed to participate in the Long-Tenn Care Pattnersbip 
program. Federal Jaw should be refom1ed to no longer prohibit the expansion of these 
h. 4 partners 1ps. 
' Cmre!llly fou1· stares ha,·c been operatmg such panncrslups that provtde an mccnuvc 10 md1viduals to purchase 
long-term care 1nsurance. tndivrdunls who purrbase wsurnnce drrough such partncrsbtps arc able to shelter a portion 
of 1beir assets. TI1e Medtcatd program saves money under such parruersh1ps because Medicatd bceomcs the payer 
after I he policy benefits are exhausted; ruak.tng Medtca1d 1be payer of last resort. not the flfSt However, it is crilical 
thul Ul<)SC LTC paymenls musl be used lo pay for LTC sei''IC<!S 
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Protect ions, such as sullabil ity. rating standards. non-forfeiture clauses. and inOation protection 
are important for individuals and states as well as to the success and potential cost-savings of the 
Pannership program. As more states arc given the ability to operate Partnership programs, 
Oexibilily to be innovative i11 such policies is important. New Partnership po licies should not be 
prescriptive ly mandated mto a single model that may beeome obsolete over time. Rec iprocity 
between slates that operate Partnership programs is an i111portaJll goal. A nationwtdc standard of 
assets should be considered as models It> implement expans ion of the program are developed in 
order to ensure that the value of asset protection purchased in tine: s tate is comparable in va lue in 
another ~lute. 
Ill. Cost Sh>lring 
Cost-Shm·ing ncspnnsihility. Stales should be given the abili ty to implelltcnt common-sciiSC, 
cnrnrceablc cost-sharing throughout the ,\kdJcatd program both to increase responsibi lity or 
Medicaid hcncliciaric.~ for the cost or their health care, um.l cnCO Ltrag..: cost-c iTccli vc care in the 
most appropriat.:: setting.~ This nc" tlexib1l it ; would be completely at s ta te opti on, and sl:Jt()s 
could choose to further restrict the types of cost-shanng 111 the p1·ogram by income leve l, 
hcncfici~' ry category, or service twc. 
• Ai or tlclow 100 percent FPL. !Existi ng cost-sharing limits woultl rema in for 
benc fi ciancs at or below the federal poverty level (with the exception ofucrcd copaysj()r 
prescription drugs as described beloh•): however, states would be given the authority lo 
make cost-sharing enforceable. No beneficiaries in U1is group could be charged a 
premium (see premtum sectton below). 
• Ahovc 100 pcrceor FPL. States would be ab le to increase cost-sharing beyond nomina l 
levels for all beneficiaries above the federal poverty level and be given U1e authority to 
make cost-sharing enforceab le. For these beneficiaries, premiums may be appropriate as 
a cost-sharing option for states and SIMes should be gtven flexibility to experiment with 
mechanisms to collect these premiums {see premium seciion below). Beneficiaries will be 
protected by a 5 percent cap on the total amoum of cost-sharing they could be responsible 
for (5 percent of total family income). Tllis could increase to 7.5 percent for those higher 
income households (defined as above ISO percent FPL). 
Premiums. Although premiums may not be appropri ate for some beneficiaries; if designed 
appropriately they arc a worthwhile cost-sharing tool. S tates should be given flexibility to 
experiment with mechanisms to collect premiums in the Medicaid program. Using premiums, 
rather than a copays would prevent beneficiaries from being denied care that they need for 
failure t.o pay when they can least afford it. It a lso introduces an insurance principle into the 
Medicaid program. Nothing in this proposal would preclude states from continuing existing 
waivers tllat include premiums as a coverage mechanism or preclude other states from en teri11g 
into such waivers with CMS. 
'Cw·rently stales arc prohibilcd from implementing cost-slmnng above nom•oallevcls (deductible is $2 per family 
pc1· 11\0IIth: CO·paymcnl from $.50 I~ $3; CO·illSllrOOce is 5 pe«:CIII or !be SIUIC ·s payment ralc for the item or 
services) nnd are proh1bi1ed from requmng. cost-shanng for certam categonc$ o f benclicmnes nnd certam serv1CCS. 
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Cost-sharing wou ld not be implemented on the fo llowing categori es of beneficiaries or services, 
as under cun·cnt law: 
• lnfanls and children under age 18 that are pro,·ided "mandatory" coverage (0-5 133 
percent FP Land 6- 18 I 00 percent FPL) 
• Preventive services ror all chtldrcn (well baby. we ll child care and immunizations); 
• Pregnant women with re;pcct to any services re lated to pregnancy or any olher medical 
condition which may complicate pregnancy; 
• Terminally ill individtwls r~'Cci v ing hospice care with respect to any service; 
• lnpallcnts in hospitals. nursing rncilittcs. o r ICFsiM R who as a condi tion of c ligibi lily arc 
requ ired tO apply most or their income to 1hc cost 11r care; 
• l!mcrgcncy services, as defined by CMS; and 
• Family pl:uming services :U1d surplics 
T iered Co-pay~ for Rx. Addillonal ly. states should b~: gi,·en the ahdity to deve lop cJ'fl;cLiv.: 
ti"r.:d co-pay structures to cncoumgc cost-ciTcctivc drug uti li;,auon where appropriate for all 
bcnclicial'ics. regard less or income. Ahhough slates may curren tly operate tiered co-pays, 
Medicaid's current cost sharing rules. with an unenforceable mruomum co-pay of $3 per drug is 
not conducive to "ncouraging cost-ciTccttvc utilization. States should be abl.: to increase co pays 
on non preferred drugs beyond nonuna l amounts when " preferred drug is avai lable, to 
encourage beneficiaries to fill the least costly effective presc ription for treatmen t. Such co pays 
must be enforceable to be meaningfu l. 
For bencliciaries at or below the federal povert y level, co-pays for preferred dntgs would remain 
nominal. although they would be enforceable. For this population. states would be able to 
increase these enforceable copays beyond nominal amounts for a non preferred dntg. States 
should be given broad authority to waive these co-pays in Ltnique circllmstanccs and cases of true 
hardship. 
IV. Benefits 
Jncrcascrl F lexibili ty to T ailor B cocfi ts to B e nc ficiary H calt b Care N ceds. Tbe Medicaid 
population is very diverse and includes medically frail ind ividuals as well as relatively healthy 
individuals that Medicaid serves as a tradirional health insurance program. Cmrcutly 
"comparabi lity" requirements limit states ' ability to tailor benefit packages to meet di fferent 
heallh care needs of beneficiaries. Reforms are necessary to allow states to design programs to 
support the health care needs of the diverse Medicaid population i11 their state. For medically 
frai l populations, chronic care management provided in a managed care model holds promise lor 
improv ing lhe health care of these ind ividuals. (see discussion of comparability and slate 
wideness in waiver reform section). 
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For relatjvcly hcnllhy indjviduals. llcxibility as IS afTorded states in the SCHIP prognun would 
allow states to design an appropnate benefit package for these bencllciaries. This llcxibi lity 
includes the ability to choose to prollide the set Medicaid benefit package or to provide a tai lored 
benefit package wllh four options for cove•age: 
I . llfmchmork ro,'crage: This is a co,·cragc package that is sul>stanlial ly equal to .:it her the 
Federal Employee J lcalth Benefits Program Blue Cross/Blue Shield Stondard Optio11 
Scrv1cc Bcnclil Pl;lJl; or a h~nlth bcnclits plan that the stat.: oiTers and makes generally 
available to its own employees: or a plan offered by a Health Maintenance Organin1 1ion 
lhat has the largest insured commcrctal. non-Mcdi<.;a1d enrollment of any ~ucl 1 
o1·ganiwtion in the state. 
2. /lonchmark equn·alent c·o,·emRe: In th1s Instance. the state must prov1dc covcmgc with an 
nggn::gmc nctuarial value 111 least equal 10 one ol the bcnchma1 k plans. States n1us1 covo.:r 
inpmicul and outpmicut hospital scrv1ces. physicians surgical and medical services, 
laboratory and X-ray scrv1ccs. and well-baby nnd wcll-cluld care, tnc ludc agc-appropnatc 
i lllll1tH1 i ~~~~ions. 
3 ExistiiiR suue-baserl comprehens11·e c·o,·erage: ln the states where cxistiug sUite-based 
comprehensive COI'cragc t:xists (e.g. state-only funded programs; or waiver populations), 
the existi11g health bcnelits package is deemed to be meeting the coverage requirements. 
4. Secreliii:J' approvPd t·ot·emge; This may inclllde coverage that is the same liS the swte's 
Medicaid program: coverage provided in a Medicatd demonst\ation pro.iect approved by 
the Secretary; or coverage purchased by the state thai is substantial ly equal lo cove1~tge 
under one of the benchmark plans through the usc of benefit-by-benefit comparison. 
SCHIP benefits flexibilny is no! being proposed for the followtng categories of beneficiaries: 
• Pregnant women, infants and ehil dre1~ under age 18 that arc provided "mandatory" 
coverage (up to age 6 133 percent FPL antl6- 18 I 00 percent FPL); 
• SSl recipients; 
• Dual eligibles: 
• Terminally ill individuals receiving hospice care; and 
• Medically frail and special needs populations 
V. Waiver Reform 
increased Ease of Waiver Approvals. Waiver applications are lime consuming and costly for 
states that seek waivers to better manage their Medicaid program and meet the needs of 
beneficia1ies. T ncreased ease for states to bypass some federal Medicaid requirements without 
having to go through a lengtl1y waiver appro,·aJ process would facilitate im1ovation in the 
program. 
States believe they and their federal partners would benefit from stales' increased nexihil ily to 
create progran1s that target special populat ions or limi ted geographic areas before expansion to 
enti re states. In many situations, smaller pi lots or experiments could iron out problems and keep 
research investment to a minimum before decisions on whether or not a program works are 
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made. With fr·eedom to create smaller experiments stales could test new care de livery and other 
concepts as well as assess demand anti beneficmryJpro ,ctder satisfaction be tb rc commi tting to an 
expensive and potentially ri sky new program. 
l'or commonly waived portions of the Medicaid statute. s tates s ho uld be a llowetl lt) usc the s late 
plan amendment process The state plan amendment process wou ld inc lude check boxes ror 
typica l waived Hems, such as those rcqu•ri ng. that bencficmrie~ have "freedom of choice" of 
provider, and that serv ices he comparable. statewide, tmd cons is tent w il11 respec t to :mtount. 
duration, and scope. S tates would rc<~ l ize cost sav ings because serv1ccs would be unplcmentcd 
sooner and States would reduce ndnumstrnli \'C costs assOCI(Itcd wi th waiver dcvc lormeut and I he 
waiv<:r amcndmcnt!rem:wal process. The rcvtscd state plan amendment would also inc lude " 
checkbox indicating limitcu gcogrnpluc scrv tcc nrcn or other limllations S imilarly, 1915(b), 
I'J I S(c) and PACE waivers should ~!so be administcr.:d through the state plan process. Ccrt;) in 
prolccti <>ns in lhe wm ver process should be 111aintaincd through this rcforll) cfrort. s uch as the 
abili ty to contro l costs antl uti li~auon common to the 1915(c) waivers. 
ro case the administrative burden for those states that have an cx tsung wa1vcr: il should 
au tomatica ll y hccome a part of the slate plan after it has been rcncwud once.'' 
Stat.es should be g1vcn more flex ibi lity w ithm waivers in provtdcr contracting. Although states 
now may contract selectively for some serv ic-es wnhout waivers, there arc m1my more serv ices 
where the abi lity to cOI\tratt v,;i th, say pre ferred prov1ders. might enable stales to em costs whi le 
improving qual ily. Contractmg nexibi luy will be imponam in pay-for-perfom1ancc (P4P) 
approaches. Addiliona l at-ri sk contracts that share savings w ilh provider groups are val uable to 
stretch increasi11gly scarce resources as they can lower care costs wh ile improving qual ity. S tate 
purchasing pools have been successfully uti I ized for pharmaceutical products, but the same 
concepts m ight be applied to other serv1ces and products if requirements can be adequately 
addressed under cwTent regulations or waivers. 
Requirements for waivers to be cost-neutral can be an unrealistic burden on new or experimental 
programs. States should be given a greater period of ti me for waiver programs to be budget 
neutral (e.g. te11 years vs. the current five year req uirement). These refonns would allow states to 
implement programs such as disease management and quality improvement that are expected to 
result in savings in later years, but have significant upfront costs. The statute should also allow 
for states to consider savings to Medicare and other federal programs when considering the 
impact of Medicaid change1;. There are many promising innovations in Med.icare/iv{edicaid 
integration or care coordination that arc never implcmemed because of outdated notions of siloed 
budget neutrality requirements. 
'' T hrough I his mechaniHn, s1a1es would be able to expeditiously replicate waivers that have been unpkmemed and 
sustaiued iD otl1cr states_ Some waive-rs are so c-ommonplace and have bc!c:u tn (Xistcncc for so long that the~' have 
become 1hc SllUldard ofprocticc. Yet curremly any new Slate lhal wan1cJ to impkrncnl a S>milar program would be 
forced to submn and defend a lengthy waiver applicalion and \\<lit for a ttmc constllnlng n:vicw. This process is 
lengthy nnd rends to discourage nmO\'Otlon by forcmg slates to make a subsronrial inves'tmcnl i.n (my ne\v programs 
wilhout much benefit to anyone. 
8 
Cm rcnl waivers should be grandfalhcred IIllO the program in order to not undermine existing 
agreements between a state and CMS. However. states should be given the opportunity to revis it 
c urrent waivers fo llowing implementation of ne" Medicaid laws at a s tate's rl!quesL 
V L. .Judicial Reform 
The right of slates to locally manage !he optional Medicaid categories is c learl y defined in botl1 
policy and law. and the federal government should remove leg;1l bHrriers tha i impetlc this 
fi.111darnental managemenl tool. Also. U.S. Departmen t of l leallh and llum<m Services of'ficials 
should have to stand hy slates when one of thc1r waivers or stole plans is questioned in lhc 
.iudic i:1l system nnd should work wilh states to define for the judiciary systcmth<l l any stale l1as a 
fi n 1damem~ l nghl to make basic opcraung deciSIOns nbou t optional categories of the pt·ogram 
VII . Mcdicnrc Rx " Cinwhack'' 
Congress m1d lhc 1\dministralion ~hou ld p:u1ncr with the stntcs to make regu latory cl1augus and 
cnacl lcgislauve fixes to lhe law to ensure that the congressiona l tntent of I he program is rcnltzcd 
and ull slates ga in some fom1 of relid from passage of the MMJ\. 
VIII. Reinvestment Options: 
As Congress considers reforms lo the Medica1d program, certain reinveslments of federal dollars 
shOLtld also be considered. r lowever, Congress should not increase the Medicaid gross cui in the 
reconcil iation bill to acc.onU110date these or any other reinvestments. The fo llowing arc some 
potentia l areas for reinvestment that need further discussion by the Governors. 
Territories. The federa l Medicaid partnersh ip with U.S. commonwealths and territories has 
become increasingly unbalanced over a period o f years, to the exlent lha l some of the 
jurisdiclions are financing over 80 percent of thei r Medicaid costs, and many of the Medicaid 
expansions such as transitional medical assistance arc not available. The imbalance affects 
access, qual ity of care, and creates increased financial stress. Medicaid reform nee-ds 10 include a 
review of the current relationship and the development of a pathway that moves tO a rebalancing 
of this partnership. 
Quality and T echnology Tmprovemeots. Grants to the states and/or an increased matching rate 
should be provided for quality improvement efforts in Medicaid, such as those being considered 
for Medicare. Such effons include adoption of health infom1ation technology; improved patient 
safety; reduction of medical errors; chronic care management; and pay- for-perfonnance. 
Tax C redits and Oeductioos for Long. Term Care lns urance. Some combination of a 
Significant tax credits, e.g., $2,000, and deductions. e.g., $200, to provide an incentive For 
individua ls to purchase long term care insurance. 
9 
Tax Credits a nd f' urchasing Pools to Increase Access to Health Ins urance. A combination of 
individu<tl health care tax credits and tax credits for small employers combined with fundi ng to 
create purchasing pools should provide assistance to low-income working indi viduals to enabk 
thcrn to obtain health insurance and avoid reliance on Medicaid. 
Fnnul and Abusr. ).~cdicaid Directors have long asked for three items to help fraud and abuse 
crlons 
I) Pcmtit states the S<LillC opportuni ti es as arc currently aiTordcd the l(;dcral govcrnrncnt to 
limit, restrict. or suspend the eligibili ty of beneficiaries and providers. subject lo du.: 
process, who have hcett determined m slaw proceedings to have engaged in frnud or 
abuse involvtng the McdJcatd program. c1•en if they have not been convtctetl in lcdcral 
cou11 of I hi: listed federa l crimes. 
2) Amend Section llJ03(a)(6) of the Social Securi ty Act to provtdc th.: same lcdcral nmtclt 
for all costs associated 11 ith fr:tud ami abuliC and Suncillnncc illld Ut ilitation Review 
Services (SURS) actJviues conducted by the state Mcdtcaid agency :ts currently received 
by the Medicaid fmutl contro l un its (75 percent). This enhanced funding wou ld apply to 
direcl Fraud and ubus~ and SUR$ functions that include, but are not limited to, 
identiiicouon. investigation, and 3dmimstrallve actions (e.g. recoveries and provider 
exclusions). 
3) Provide that when a state discovers an overpayment and detcm1incs it to be auributable to 
fi·aud or abuse. the slate should refund the federal overpayment in the quarter in which 
the recovery is made, regard less of when the overpayment is discovered. 
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SHORT-RUN MEDICAID REFORM 
Report of The National Governors Association, August 29, 2005 
 
 
Overview & Recommendations 
On August 29, 2005 the National Governors Association released a report entitled Short-run Medicaid Reform.  The report notes that the  
recommendations are proposed “as good public policy not to satisfy any spending reduction target.”  The report also notes that the 
Governors Association looks forward to working with the federal Medicaid Commission as they focus on the long-run restructuring of 
Medicaid. 
 
Subject  Recommendation 
Prescription Drugs • Switch the federal ceiling for drug pricing from Average Wholesale Price (AWP) to Average 
Manufacturer Price (AMP), allowing states to negotiate lower prices.  Institute reforms to better inform 
states and ensure accuracy of manufacturer data. 
• Allow states to adopt closed formularies. 
• Allow states flexibility in determining dispensing fees. 
• Increase state’s minimum rebates on brand name drugs to 20%, retaining the “best-price” requirement. 
• Ensure that all drugs are included in “best-price” and “authorized generics” calculations, and that 
“authorized generic” qualifies a drug for the federal upper limit. 
• Allow Medicaid managed care companies direct access to drug rebates, allowing the state to collect the 
rebate directly or to allow the plan access to the rebates and to lower capitation payments. 
• Allow states greater flexibility in establishing purchasing pools – allowing combining of populations and 
Medicaid level prices for state funded drug programs.    
• Establish a new federal reimbursement ceiling for drugs, retaining the federal upper limit, based on AMP. 
• Allow states to require use of mail order pharmacies for maintenance drugs. 
Long-term Care • With regard to asset transfer, increase the look-back period from 3 to 5 years, begin penalty period on date 
of application and prevent sheltering of excess resources in annuities, trusts and promissory notes.   
Tighten asset transfer rules.   Include as assets entrance deposits for continuing care retirement 
community and life care facilities.  
• Include home equity as a countable asset, allowing reverse mortgage upfront costs to be assumed into the 
mortgage annual payout.  Give states an option to allow partial sheltering of home value in exchange for 
reverse mortgaging that pays for medical and long-term care expenses.   
• Allow states to participate in the Long-term Care Partnership Program, providing flexibility while 
providing national standards. 
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Subject  Recommendations 
Cost Sharing • Give states the option to implement enforceable cost sharing.   Maintain existing cost sharing at or below 
federal poverty level.  Allow states to implement enforceable cost-sharing and premiums for beneficiaries 
above federal poverty level.  Allow states to develop tiered, enforceable prescription drug co-pays for all 
beneficiaries. 
Benefits • Allow states flexibility to tailor benefit programs to different populations.  For relatively healthy persons, 
the benefit package could be (1) the federal package or another benchmark, (2) coverage at an actuarial 
benchmark equivalent, (3) existing state-based comprehensive coverage, or (4) coverage approved by the 
Secretary of CMS. 
Waiver Reform • Streamline the waiver process, allowing more limited population or geographic area pilots and changes by 
state plan amendment instead of waiver.   
• Allow renewed waivers to become part of the state plan and current waivers to continue, with state 
opportunity to revisit the waiver later.   
• Allow more flexibility within waivers for provider contracting.   
• Extend time period for waiver cost neutrality and allow consideration of savings to Medicare and other 
federal programs.    
Judicial Reform • Remove federal legal barriers to state management of optional Medicaid categories.    
• Require federal DHHS to stand by states when their waivers or state plans are challenged in court. 
Medicare Rx Clawback • Make changes on federal level to ensure that congressional intent of Medicare Modernization Act is 
realized and all states gain from its passage. 
Reinvestment Options • Consideration of certain reinvestment on the federal level, without increasing Medicaid gross cut. 
• Review and rebalance partnership of federal government with the territories. 
• Fund quality and technology improvements in the states, through grants or increased matching rates. 
• Provide significant tax credits as incentives to purchasing long-term care insurance.  
• Provide tax credits for individuals and small employers and fund purchasing pools. 
• Allow states the tools for fraud and abuse prevention – through suspending eligibility of beneficiaries and 
providers, increase federal match for Surveillance and Utilization Review Services, and allow state 
repayment of federal match for overpayment due to fraud or abuse in the quarter that the overpayment is 
discovered. 
 
 
 
 
